recw20112
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number:
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or |
(IRS Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|||
|
|
|||
|
|
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b‑2 of the Exchange Act:
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
☒ |
Smaller reporting company |
||
|
|
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b‑2 of the Act). Yes ☐ No
As of April 30, 2024, the registrant had
TRINITY CAPITAL INC.
FORM 10‑Q FOR THE QUARTER ENDED MARCH 31, 2024
TABLE OF CONTENTS
PART I: FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
TRINITY CAPITAL INC.
Consolidated Statements of Assets and Liabilities
(In thousands, except share and per share data)
|
|
March 31, |
|
|
December 31, |
|
||
|
|
2024 |
|
|
2023 |
|
||
|
|
(Unaudited) |
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
||
Investments at fair value: |
|
|
|
|
|
|
||
Control investments (cost of $ |
|
$ |
|
|
$ |
|
||
Affiliate investments (cost of $ |
|
|
|
|
|
|
||
Non-Control / Non-Affiliate investments (cost of $ |
|
|
|
|
|
|
||
Total investments (cost of $ |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
|
||
Interest receivable |
|
|
|
|
|
|
||
Deferred credit facility costs |
|
|
|
|
|
|
||
Other assets |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
LIABILITIES |
|
|
|
|
|
|
||
KeyBank Credit Facility |
|
$ |
|
|
$ |
|
||
2025 Notes, net of $ |
|
|
|
|
|
|
||
August 2026 Notes, net of $ |
|
|
|
|
|
|
||
March 2029 Notes, net of $ |
|
|
|
|
|
— |
|
|
December 2026 Notes, net of $ |
|
|
|
|
|
|
||
Convertible Notes, net of $ |
|
|
|
|
|
|
||
Distribution payable |
|
|
|
|
|
|
||
Security deposits |
|
|
|
|
|
|
||
Accounts payable, accrued expenses and other liabilities |
|
|
|
|
|
|
||
Total liabilities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
||
NET ASSETS |
|
|
|
|
|
|
||
Common stock, $ |
|
|
|
|
|
|
||
Paid-in capital in excess of par |
|
|
|
|
|
|
||
Distributable earnings/(accumulated deficit) |
|
|
( |
) |
|
|
( |
) |
Total net assets |
|
|
|
|
|
|
||
Total liabilities and net assets |
|
$ |
|
|
$ |
|
||
NET ASSET VALUE PER SHARE |
|
$ |
|
|
$ |
|
See accompanying notes to unaudited consolidated financial statements.
3
TRINITY CAPITAL INC.
Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
||||
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
|
||||
INVESTMENT INCOME: |
|
|
|
|
|
|
|
|
|
||
Interest and dividend income: |
|
|
|
|
|
|
|
|
|
||
Control investments |
|
$ |
|
|
|
$ |
|
|
|
||
Affiliate investments |
|
|
|
|
|
|
|
|
|
||
Non-Control / Non-Affiliate investments |
|
|
|
|
|
|
|
|
|
||
Total interest and dividend income |
|
|
|
|
|
|
|
|
|
||
Fee and other income: |
|
|
|
|
|
|
|
|
|
||
Affiliate investments |
|
|
|
|
|
|
|
|
|
||
Non-Control / Non-Affiliate investments |
|
|
|
|
|
|
|
|
|
||
Total fee and other income |
|
|
|
|
|
|
|
|
|
||
Total investment income |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
EXPENSES: |
|
|
|
|
|
|
|
|
|
||
Interest expense and other debt financing costs |
|
|
|
|
|
|
|
|
|
||
Compensation and benefits |
|
|
|
|
|
|
|
|
|
||
Professional fees |
|
|
|
|
|
|
|
|
|
||
General and administrative |
|
|
|
|
|
|
|
|
|
||
Total expenses |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
NET INVESTMENT INCOME/(LOSS) BEFORE TAXES |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
Excise tax expense |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
NET INVESTMENT INCOME |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
NET REALIZED GAIN/(LOSS) FROM INVESTMENTS: |
|
|
|
|
|
|
|
|
|
||
Non-Control / Non-Affiliate investments |
|
|
|
|
|
|
|
( |
) |
|
|
Net realized gain/(loss) from investments |
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
||
NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS: |
|
|
|
|
|
|
|
|
|
||
Control investments |
|
|
|
|
|
|
|
|
|
||
Affiliate investments |
|
|
|
|
|
|
|
|
|
||
Non-Control / Non-Affiliate investments |
|
|
|
( |
) |
|
|
|
|
|
|
Net change in unrealized appreciation/(depreciation) from investments |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS |
|
$ |
|
|
|
$ |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
NET INVESTMENT INCOME PER SHARE - BASIC |
|
$ |
|
|
|
$ |
|
|
|
||
NET INVESTMENT INCOME PER SHARE - DILUTED |
|
$ |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC |
|
$ |
|
|
|
$ |
|
|
|
||
NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - DILUTED |
|
$ |
|
|
|
$ |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC |
|
|
|
|
|
|
|
|
|
||
WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED |
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited consolidated financial statements.
4
TRINITY CAPITAL INC.
Consolidated Statements of Changes in Net Assets
(In thousands, except share and per share data)
(Unaudited)
Three Months Ended March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
Distributable |
|
|
|
|
|||||
|
|
|
|
|
|
|
|
Paid In Capital |
|
|
Earnings / |
|
|
|
|
|||||
|
|
Common Stock |
|
|
in Excess of |
|
|
(Accumulated |
|
|
Total |
|
||||||||
|
|
Shares |
|
|
Par Value |
|
|
Par Value |
|
|
Loss) |
|
|
Net Assets |
|
|||||
Balance as of December 31, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Issuance of common stock pursuant to distribution reinvestment plan |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|||
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Issuance of restricted stock awards |
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
||
Issuance of common stock, net of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||
Retired and forfeited shares of restricted stock |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Stock repurchase and cancellation of shares |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Distributions to stockholders |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Net increase/(decrease) in net assets resulting from operations |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||
Balance as of March 31, 2024 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
Three Months Ended March 31, 2023:
|
|
|
|
|
|
|
|
|
|
|
Distributable |
|
|
|
|
|||||
|
|
|
|
|
|
|
|
Paid In Capital |
|
|
Earnings / |
|
|
|
|
|||||
|
|
Common Stock |
|
|
in Excess of |
|
|
(Accumulated |
|
|
Total |
|
||||||||
|
|
Shares |
|
|
Par Value |
|
|
Par Value |
|
|
Loss) |
|
|
Net Assets |
|
|||||
Balance as of December 31, 2022 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Issuance of common stock pursuant to distribution reinvestment plan |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|||
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Issuance of restricted stock awards |
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
||
Issuance of common stock, net of issuance costs |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|||
Retired and forfeited shares of restricted stock |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Stock repurchase and cancellation of shares |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Distributions to stockholders |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Net increase/(decrease) in net assets resulting from operations |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||
Balance as of March 31, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
See accompanying notes to unaudited consolidated financial statements.
5
TRINITY CAPITAL INC.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
||
Cash flows provided by/(used in) operating activities: |
|
|
|
|
|
|
||
Net increase/(decrease) in net assets resulting from operations |
|
$ |
|
|
$ |
|
||
Adjustments to reconcile net increase/(decrease) in net assets resulting from operation to net cash provided by/(used in) operating activities: |
|
|
|
|
|
|
||
Purchase of investments, net of deferred fees |
|
|
( |
) |
|
|
( |
) |
Proceeds from sales and paydowns of investments |
|
|
|
|
|
|
||
Net change in unrealized appreciation/(depreciation) from investments, net of third party participation |
|
|
|
|
|
( |
) |
|
Net realized gain/(loss) from investments |
|
|
( |
) |
|
|
|
|
Accretion of original issue discounts and end of term payments on investments |
|
|
( |
) |
|
|
( |
) |
Amortization of deferred financing costs |
|
|
|
|
|
|
||
Stock-based compensation |
|
|
|
|
|
|
||
Change in operating assets and liabilities |
|
|
|
|
|
|
||
(Increase)/Decrease in interest receivable |
|
|
( |
) |
|
|
( |
) |
(Increase)/Decrease in other assets |
|
|
( |
) |
|
|
( |
) |
Increase/(Decrease) in security deposits |
|
|
( |
) |
|
|
|
|
Increase/(Decrease) in accounts payable, accrued expenses and other liabilities |
|
|
( |
) |
|
|
( |
) |
Net cash provided by/(used in) operating activities |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
||
Cash flows provided by/(used in) investing activities: |
|
|
|
|
|
|
||
Disposal/(Acquisition) of fixed assets |
|
|
( |
) |
|
|
( |
) |
Net cash provided by/(used in) investing activities |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
||
Cash flows provided by/(used in) financing activities |
|
|
|
|
|
|
||
Issuance of common stock, net of issuance costs |
|
|
|
|
|
|
||
Stock repurchase and cancellation of shares, net of costs |
|
|
— |
|
|
|
( |
) |
Retirement of employee shares |
|
|
( |
) |
|
|
( |
) |
Cash distributions paid |
|
|
( |
) |
|
|
( |
) |
Issuance of debt, net of issuance costs |
|
|
|
|
|
— |
|
|
Borrowings under Credit Facilities |
|
|
|
|
|
|
||
Repayments under Credit Facilities |
|
|
( |
) |
|
|
( |
) |
Net cash provided by/(used in) financing activities |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
||
Net increase/(decrease) in cash, cash equivalents and restricted cash |
|
|
|
|
|
( |
) |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|
|
|
|
||
Cash, cash equivalents and restricted cash at end of period |
|
$ |
|
|
$ |
|
6
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
||
Supplemental and non-cash investing and financing activities: |
|
|
|
|
|
|
||
Cash paid for interest |
|
$ |
|
|
$ |
|
||
Non-cash settlement of investments |
|
$ |
— |
|
|
$ |
|
|
Accrued but unpaid distributions |
|
$ |
|
|
$ |
|
||
Distributions reinvested |
|
$ |
|
|
$ |
|
||
Income tax, including excise tax, paid |
|
$ |
|
|
$ |
|
See accompanying notes to unaudited consolidated financial statements.
7
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Artificial Intelligence & Automation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Ambient Photonics, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Ambient Photonics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Applied Digital Corporation |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Applied Digital Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rigetti & Co, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Rigetti & Co, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Stratifyd, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Artificial Intelligence & Automation ( |
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Biotechnology |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Greenlight Biosciences Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Greenlight Biosciences Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Pendulum Therapeutics, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Pendulum Therapeutics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Taysha Gene Therapies, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Biotechnology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
8
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Connectivity |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Vertical Communications, Inc.(20) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
viaPhoton, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Connectivity ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Consumer Products & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Eterneva, Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Eterneva, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Happiest Baby, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Molekule, Inc. |
|
Equipment Financing(14)(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Molekule, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Ogee, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Ogee, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Portofino Labs, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Quip NYC, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Quip NYC, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rinse, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
V |
|
|
|
|
|
|
|
|
|
|||||
Total Rinse, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SI Tickets, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
UnTuckIt, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
VitaCup, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Whoop, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Whoop, Inc. |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Consumer Products & Services ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
9
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Diagnostics & Tools |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Metabolon, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Diagnostics & Tools ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Digital Assets Technology and Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cleanspark, Inc.(10) |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Digital Assets Technology and Services ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Education Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Edblox, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Medical Sales Training Holding Company |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Medical Sales Training Holding Company |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Yellowbrick Learning, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Yellowbrick Learning, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Education Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
10
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Finance and Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Bestow, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Bestow, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cherry Technologies, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Empower Financial, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Empower Financial, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Eqis Capital Management, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Kafene, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Openly Holdings Corp. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Openly Holdings Corp. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Parafin SPV 2, LLC(10) |
|
Secured Loan(12)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Petal Card, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Petal Card, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Slope Tech, Inc.(10) |
|
Secured Loan(12)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
ZenDrive, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Finance and Insurance ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
11
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Food and Agriculture Technologies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Athletic Brewing Company, LLC |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Athletic Brewing Company, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Bowery Farming, Inc. |
|
Secured Loan(14)(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Daring Foods, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Daring Foods, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
DrinkPak, LLC |
|
Equipment Financing(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emergy, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Emergy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Intelligent Brands, Inc. (f.k.a. Sun Basket, Inc.) |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
The Fynder Group, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total The Fynder Group, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Food and Agriculture Technologies ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
12
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Green Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Bolb, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Commonwealth Fusion Systems, LLC |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Commonwealth Fusion Systems, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Crusoe Energy Systems LLC |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dandelion Energy, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Dandelion Energy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Electric Hydrogen Co. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Electric Hydrogen Co. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hi-Power, LLC |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Hi-Power, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SeaOn Global, LLC |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total SeaOn Global, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Edeniq, Inc.(20) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Footprint International Holding, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Footprint International Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Mainspring Energy, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
RTS Holding, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total RTS Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Green Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
13
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Healthcare Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emerald Cloud Lab, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dentologie Enterprises, Inc. |
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Dentologie Enterprises, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Lark Technologies, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Lark Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Moxe Health Corporation |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
RXAnte, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total RXAnte, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
TMRW Life Sciences, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total TMRW Life Sciences, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
WorkWell Prevention & Care Inc. |
|
Secured Loan(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Healthcare Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
14
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Human Resource Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nomad Health, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Human Resource Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
3DEO, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total 3DEO, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Formlogic Corporation |
|
Equipment Financing(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Industrials ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Marketing, Media, and Entertainment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Drone Racing League, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Grabit Interactive Media, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Incontext Solutions, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
PebblePost, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Vox Media Holdings, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Vox Media Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Marketing, Media, and Entertainment ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
15
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Medical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Convergent Dental, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Convergent Dental, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Neurolens, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Neuros Medical, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Revelle Aesthetics, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Shoulder Innovations, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Medical Devices ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Multi-Sector Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Senior Credit Corp 2022 LLC (10)(20) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Multi-Sector Holdings ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Real Estate Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BlueGround US, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total BlueGround US, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BoardRE, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Knockaway, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(12) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Knockaway, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Maxwell Financial Labs, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Orchard Technologies, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Real Estate Technology ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
16
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Software as a Service ("SaaS") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BackBlaze, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total BackBlaze, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cart.com, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cpacket Networks, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: SaaS ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Astranis Space Technology Corporation |
|
Equipment Financing(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Axiom Space, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hadrian Automation, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Hadrian Automation, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hermeus Corporation |
|
Equipment Financing(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Hermeus Corporation |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rocket Lab USA, Inc.(10) |
|
Equipment Financing(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Perspective, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Space Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
17
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Macrofab, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Supply Chain Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Transportation Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
NextCar Holding Company, Inc. |
|
Secured Loan(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total NextCar Holding Company, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Get Spiffy, Inc. |
|
Secured Loan(9) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(9) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Get Spiffy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Zuum Transportation, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Transportation Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities- United States ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
18
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nexii Building Solutions, Inc. (10) |
|
Secured Loan(14)(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Nexii Building Solutions, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Construction Technology ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
GoFor Industries, Inc. (10)(20) |
|
Secured Loan(14)(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total GoFor Industries, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Supply Chain Technology ( |
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities- Canada ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Debt Securities- Europe |
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Aledia, Inc. (10) |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Aledia, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Industrials ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
All.Space Networks, Limited.(10) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Space Technology ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities- Europe ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
19
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Artificial Intelligence & Automation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Ambient Photonics, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Everalbum, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Hologram, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Presto Automation, Inc. |
|
Warrant(7) |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(7) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Presto Automation, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Stratifyd, Inc. |
|
Warrant |
|
|
|
Preferred Series B-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Artificial Intelligence & Automation ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Biotechnology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Pendulum Therapeutics, Inc. |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Pendulum Therapeutics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Biotechnology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Connectivity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Tarana Wireless, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Vertical Communications, Inc. (20) |
|
Warrant⁽¹¹⁾ |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
viaPhoton, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Connectivity ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Project Frog, Inc. (20) |
|
Warrant |
|
|
|
Preferred Series AA-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Series CC⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Project Frog, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
20
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Consumer Products & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
BaubleBar, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total BaubleBar, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Boosted eCommerce, Inc. |
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Happiest Baby, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Madison Reed, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Madison Reed, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Ogee, Inc. |
|
Warrant |
|
|
|
Preferred Series A-3⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-3⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Ogee, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Portofino Labs, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Portofino Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Quip NYC, Inc. |
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Rinse, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
SI Tickets, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Super73, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Trendly, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
VitaCup, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant⁽¹¹⁾ |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
— |
|
|
|
— |
|
||||
Total VitaCup, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Whoop, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Consumer Products & Services ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diagnostics & Tools |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Metabolon, Inc. |
|
Warrant |
|
|
|
Preferred Series 3⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-total: Diagnostics & Tools ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
21
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Education Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Edblox, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Medical Sales Training Holding Company |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Yellowbrick Learning, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Education Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Finance and Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
DailyPay, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dynamics, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Empower Financial, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Eqis Capital Management, Inc. |
|
Warrant |
|
|
|
Preferred Class B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Kafene, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Parafin, Inc.(10) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Petal Card, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Petal Card, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
RealtyMogul, Co. |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Slope Tech, Inc.(10) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Slope Tech, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
ZenDrive, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Finance and Insurance ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Food and Agriculture Technologies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Athletic Brewing Company, LLC |
|
Warrant |
|
|
|
Preferred Class B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Bowery Farming, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Bowery Farming, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Daring Foods, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
DrinkPak, LLC |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total DrinkPak, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Emergy, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GrubMarket, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Intelligent Brands, Inc. (f.k.a. PSB Holdings, Inc.) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Intelligent Brands, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
The Fynder Group, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Zero Acre Farms, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Food and Agriculture Technologies ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
22
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Green Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Bolb, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Edeniq, Inc. |
|
Warrant(11) |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
— |
|
||||
|
|
Warrant(11) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Edeniq, Inc.(20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Footprint International Holding, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Footprint International Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Mainspring Energy, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Mainspring Energy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
RTS Holding, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred Series D-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total RTS Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Green Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Healthcare Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dentologie Enterprises, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Exer Holdings, LLC |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Hospitalists Now, Inc. |
|
Warrant |
|
|
|
Preferred Series D-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series D-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Hospitalists Now, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Lark Technologies, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Lark Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Moxe Health Corporation |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
RXAnte, Inc. |
|
Warrant(9) |
|
|
|
Preferred A |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred A |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred A |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total RXAnte, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
TMRW Life Sciences, Inc. |
|
Warrant |
|
|
|
Preferred Class A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Class A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total TMRW Life Sciences, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Healthcare Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
23
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Human Resource Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
BetterLeap, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Qwick, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Human Resource Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
3DEO, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
SBG Labs, Inc. |
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total SBG Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-total: Industrials ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Marketing, Media, and Entertainment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Drone Racing League, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Firefly Systems, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Grabit Interactive Media, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Incontext Solutions, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
PebblePost, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Marketing, Media, and Entertainment ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Medical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Convergent Dental, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Delphinus, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series E⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Neuros Medical, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revelle Aesthetics, Inc. |
|
Warrant |
|
|
|
Preferred Series A-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Shoulder Innovations, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Medical Devices ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
24
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Real Estate Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Homelight, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Knockaway, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant⁽¹¹⁾ |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
— |
|
|
|
— |
|
||||
|
|
Warrant⁽¹¹⁾ |
|
|
|
Preferred Series AA⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
— |
|
||||
Total Knockaway, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Maxwell Financial Labs, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Maxwell Financial Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Orchard Technologies, Inc. |
|
Warrant⁽¹¹⁾ |
|
|
|
Preferred Series 1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Real Estate Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
SaaS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
All Seated, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cart.com, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cpacket Networks, Inc. |
|
Warrant |
|
|
|
Preferred Class B Common⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Crowdtap, Inc. |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Crowdtap, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Gtxcel, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Gtxcel, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Lucidworks, Inc. |
|
Warrant |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Reciprocity, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Reciprocity, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Smartly, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
The Tomorrow Companies, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: SaaS ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
25
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Astranis Space Technology Corporation |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Axiom Space, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Axiom Space, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Hermeus Corporation |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Rocket Lab USA, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Space Perspective, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Space Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Macrofab, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Supply Chain Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Transportation Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Get Spiffy, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
NextCar Holding Company, Inc. |
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
Total NextCar Holding Company, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Transportation Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- United States ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
26
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Nexii Building Solutions, Inc. (10) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
(13) |
$ |
|
(13) |
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
Total Nexii Building Solutions, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- Canada ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Warrant Investments- Europe |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Aledia, Inc. (10) |
|
Warrant |
|
|
|
Preferred Series D-3⁽¹⁷⁾ |
|
|
|
(13) |
$ |
|
(13) |
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Information ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
All.Space Networks, Limited. (10) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Space Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- Europe (0.0%)* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
27
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Shares / Principal |
|
|
Series |
|
Cost |
|
|
Fair Value (6) |
|
|||
Equity Investments- United States |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Artificial Intelligence & Automation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rigetti & Co, Inc. |
|
Equity(7) |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
|
||||
|
|
Equity(7) |
|
|
|
|
|
Common Stock |
|
|
|
|
|
|
||||
Total Rigetti & Co, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Artificial Intelligence & Automation ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Connectivity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Tarana Wireless, Inc. |
|
Equity⁽¹⁴⁾ |
|
|
|
|
|
Preferred Series 6⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Vertical Communications, Inc. |
|
Equity⁽¹¹⁾⁽¹⁴⁾ |
|
|
|
|
|
Preferred Series 1⁽¹⁷⁾ |
|
$ |
— |
|
|
$ |
— |
|
||
|
|
Equity⁽¹⁴⁾ |
|
|
$ |
|
|
Convertible Note⁽¹⁶⁾ |
|
|
|
|
|
|
||||
Total Vertical Communications, Inc. (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Connectivity ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Project Frog, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series AA-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series BB⁽¹⁷⁾ |
|
|
|
|
|
— |
|
|||
|
|
Equity |
|
|
|
|
|
Common Stock |
|
|
|
|
|
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series CC⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total Project Frog, Inc. (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Consumer Products & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Portofino Labs, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Quip NYC, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Consumer Products & Services ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Digital Assets Technology and Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Core Scientific, Inc. |
|
Equity(7) |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Digital Assets Technology and Services ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Finance and Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dynamics, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Openly Holdings Corp. |
|
Equity |
|
|
|
|
|
Series D |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Slope Tech, Inc.(10) |
|
Equity |
|
|
|
|
|
Preferred Series A-3⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Finance and Insurance ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Food and Agriculture Technologies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emergy, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Intelligent Brands, Inc. (f.k.a. Pruvit Ventures, Inc.) |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Food and Agriculture Technologies ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
28
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Shares / Principal |
|
|
Series |
|
Cost |
|
|
Fair Value (6) |
|
|||
Equity Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Green Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Edeniq, Inc. |
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
— |
|
|
$ |
|
|||
|
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
— |
|
|
|
|
|||
|
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
— |
|
|
|
|
|||
Total Edeniq, Inc. (20) |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Electric Hydrogen Co. |
|
Equity |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Mainspring Energy, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series E-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
RTS Holding, Inc. |
|
Equity(9) |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity(9) |
|
|
|
|
|
Preferred Series D-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total RTS Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Green Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Healthcare Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dentologie Enterprises, Inc. |
|
Equity(9) |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emerald Cloud Lab, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Lark Technologies, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
WorkWell Prevention & Care Inc. |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series P⁽¹⁷⁾ |
|
|
|
|
|
— |
|
|||
|
|
Equity |
|
|
$ |
|
|
Convertible Note⁽¹⁶⁾ |
|
|
|
|
|
— |
|
|||
Total WorkWell Prevention & Care Inc. (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Healthcare Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Human Resource Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nomad Health, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series D-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Human Resource Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SBG Labs, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity |
|
|
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
|
|
Equity |
|
|
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total SBG Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Industrials ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Multi-Sector Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Senior Credit Corp 2022 LLC(10)(20) |
|
Equity(7) |
|
|
|
- |
|
|
Preferred ⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Multi-Sector Holdings ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Real Estate Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Knockaway, Inc. |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series AA⁽¹⁷⁾ |
|
|
|
|
|
— |
|
|||
Total Knockaway Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Orchard Technologies, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity |
|
|
|
|
|
Preferred Series 1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total Orchard Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Maxwell Financial Labs, Inc |
|
Equity |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Real Estate Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
29
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Shares / Principal |
|
|
Series |
|
Cost |
|
|
Fair Value (6) |
|
|||
Equity Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SaaS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Smartly, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
The Tomorrow Companies, Inc. |
|
Equity(9) |
|
|
|
|
|
Preferred Series E-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: SaaS ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Astranis Space Technology Corporation |
|
Equity(9) |
|
|
|
|
|
Series C Prime Preferred⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity(9) |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Axiom Space, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hadrian Automation, Inc. |
|
Equity |
|
|
|
|
|
Preferred A-4⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity(9) |
|
|
|
|
|
Preferred B-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total Hadrian Automation, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Space Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
3Q GoFor Holdings, LP (21) |
|
Equity |
|
|
|
— |
|
|
Preferred ⁽¹⁷⁾ |
|
$ |
|
|
$ |
— |
|
||
|
|
Equity |
|
|
|
— |
|
|
Preferred ⁽¹⁷⁾ |
|
|
|
|
|
— |
|
||
Total 3Q GoFor Holdings, LP (21) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Macrofab, Inc. |
|
Equity |
|
|
|
|
|
Preferred C-1 Preferred⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Supply Chain Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Equity Investments- United States ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Equity Investments- Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nexii Building Solutions, Inc. (10) |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Equity Investments- Canada ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Equity Investments ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total Investment in Securities ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cash and Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Goldman Sachs Financial Square Government Institutional Fund |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
Other cash accounts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cash and Cash Equivalents ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total Portfolio Investments and Cash and Cash Equivalents ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
*
30
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
31
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
March 31, 2024
(In thousands, except share and per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in |
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|||||||
|
|
Fair Value at |
|
|
Gross |
|
|
Gross |
|
|
Realized |
|
|
(Depreciation)/ |
|
|
Fair Value at |
|
|
Interest and |
|
|||||||
|
|
December 31, 2023 |
|
|
Additions (1) |
|
|
Reductions (2) |
|
|
Gain/(Loss) |
|
|
Appreciation |
|
|
March 31, 2024 |
|
|
Dividend Income |
|
|||||||
For the Three Months Ended March 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Control Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Edeniq, Inc. |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
3Q GoFor Holdings, LP |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
|||
Project Frog, Inc. |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|||
Vertical Communications, Inc. |
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|||||
WorkWell Prevention and Care Inc. |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|||
Total Control Investments |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Affiliate Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Senior Credit Corp 2022 LLC |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|||||
Total Affiliate Investments |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Total Control and Affiliate Investments |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
32
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Artificial Intelligence & Automation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Ambient Photonics, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Ambient Photonics, Inc. |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rigetti & Co, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Rigetti & Co, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Stratifyd, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Artificial Intelligence & Automation ( |
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Biotechnology |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Greenlight Biosciences Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Greenlight Biosciences Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Pendulum Therapeutics, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Pendulum Therapeutics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Taysha Gene Therapies, Inc.(10) |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Biotechnology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
33
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Connectivity |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Vertical Communications, Inc.(20) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
viaPhoton, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Connectivity ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Consumer Products & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Eterneva, Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Eterneva, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Happiest Baby, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Molekule, Inc. |
|
Equipment Financing(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Molekule, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Ogee, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Ogee, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Portofino Labs, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Quip NYC, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Quip NYC, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rinse, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Rinse, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SI Tickets, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
UnTuckIt, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
VitaCup, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Whoop, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Consumer Products & Services ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
34
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Digital Assets Technology and Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cleanspark, Inc.(10) |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Core Scientific, Inc. |
|
Equipment Financing(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Core Scientific, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Digital Assets Technology and Services ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Education Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Medical Sales Training Holding Company |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Medical Sales Training Holding Company |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Yellowbrick Learning, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Yellowbrick Learning, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Education Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
35
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Finance and Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Bestow, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Bestow, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Empower Financial, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Eqis Capital Management, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Openly Holdings Corp. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Openly Holdings Corp. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Petal Card, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Petal Card, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Slope Tech, Inc. |
|
Secured Loan(12)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
ZenDrive, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Finance and Insurance ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
36
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Food and Agriculture Technologies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Athletic Brewing Company, LLC |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Athletic Brewing Company, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Bowery Farming, Inc. |
|
Secured Loan(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Daring Foods, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Daring Foods, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
DrinkPak, LLC |
|
Equipment Financing(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emergy, Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Emergy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Intelligent Brands, Inc. (f.k.a. Sun Basket, Inc.) |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
The Fynder Group, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total The Fynder Group, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Food and Agriculture Technologies ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
37
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Green Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Bolb, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Commonwealth Fusion Systems, LLC |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Commonwealth Fusion Systems, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dandelion Energy, Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Dandelion Energy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Electric Hydrogen Co. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Electric Hydrogen Co. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hi-Power, LLC |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Hi-Power, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SeaOn Global, LLC |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total SeaOn Global, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Edeniq, Inc.(20) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Footprint International Holding, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Footprint International Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Mainspring Energy, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
RTS Holding, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total RTS Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Green Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
38
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Healthcare Technology ** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emerald Cloud Lab, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dentologie Enterprises, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Dentologie Enterprises, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Lark Technologies, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Lark Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
WorkWell Prevention & Care Inc. |
|
Secured Loan(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Moxe Health Corporation |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
RXAnte, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total RXAnte, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
TMRW Life Sciences, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total TMRW Life Sciences, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Healthcare Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
39
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Human Resource Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nomad Health, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Human Resource Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
3DEO, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total 3DEO, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Formlogic Corporation |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Industrials ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Marketing, Media, and Entertainment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Drone Racing League, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Grabit Interactive Media, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Incontext Solutions, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
PebblePost, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Vox Media Holdings, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Vox Media Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Marketing, Media, and Entertainment ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
40
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Medical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Convergent Dental, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Delphinus Medical Technologies, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Neurolens, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Neuros Medical, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Revelle Aesthetics, Inc. |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Shoulder Innovations, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Medical Devices ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Multi-Sector Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Senior Credit Corp 2022 LLC (10)(20) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Multi-Sector Holdings ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Real Estate Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BlueGround US, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total BlueGround US, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BoardRE, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Knockaway, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Knockaway, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Maxwell Financial Labs, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Orchard Technologies, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Orchard Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Real Estate Technology ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
41
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Software as a Service ("SaaS") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BackBlaze, Inc. |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total BackBlaze, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cart.com, Inc. |
|
Secured Loan(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: SaaS ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Astranis Space Technology Corporation |
|
Equipment Financing(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Axiom Space, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hadrian Automation, Inc. |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Hadrian Automation, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hermeus Corporation |
|
Equipment Financing(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Hermeus Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rocket Lab USA, Inc.(10) |
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing⁽¹⁴⁾ |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Rocket Lab USA, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Perspective, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Space Technology ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
42
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Macrofab, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Supply Chain Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Transportation Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
NextCar Holding Company, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total NextCar Holding Company, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Get Spiffy, Inc. |
|
Secured Loan(9)(14) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing(9)(14) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Get Spiffy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Zuum Transportation, Inc. |
|
Secured Loan |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Transportation Technology ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities- United States ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
43
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of Investment (2) |
|
Investment Date (3) |
|
Maturity Date |
|
Interest Rate (4) |
|
Principal |
|
|
Cost |
|
|
Fair Value (6) |
|
|||
Debt Securities- Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nexii Building Solutions, Inc.(10) |
|
Secured Loan(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Secured Loan(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Secured Loan(14)(18) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Nexii Building Solutions, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Construction Technology ( |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
GoFor Industries, Inc.(10)(20) |
|
Secured Loan(18) |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Supply Chain Technology ( |
|
$ |
|
|
$ |
|
|
$ |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities- Canada ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Debt Securities- Europe |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Aledia, Inc.(10) |
|
Equipment Financing |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Aledia, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Industrials ( |
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
All.Space Networks, Limited.(10) |
|
Secured Loan⁽¹⁴⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Space Technology ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities- Europe ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Debt Securities ( |
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
44
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Artificial Intelligence & Automation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Ambient Photonics, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Everalbum, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Hologram, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Presto Automation, Inc. |
|
Warrant(7) |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(7) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Presto Automation, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Stratifyd, Inc. |
|
Warrant |
|
|
|
Preferred Series B-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Artificial Intelligence & Automation ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Biotechnology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Pendulum Therapeutics, Inc. |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Pendulum Therapeutics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Biotechnology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Connectivity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Tarana Wireless, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Vertical Communications, Inc.(20) |
|
Warrant⁽¹¹⁾ |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
viaPhoton, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Connectivity ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Project Frog, Inc.(20) |
|
Warrant |
|
|
|
Preferred Series AA-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Series CC⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Project Frog, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
45
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Consumer Products & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
BaubleBar, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total BaubleBar, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Boosted eCommerce, Inc. |
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Happiest Baby, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Madison Reed, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Madison Reed, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Ogee, Inc. |
|
Warrant |
|
|
|
Preferred Series A-3⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-3⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Ogee, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Portofino Labs, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Portofino Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Quip NYC, Inc. |
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Rinse, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
SI Tickets, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Super73, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Trendly, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
VitaCup, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant⁽¹¹⁾ |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
— |
|
|
|
— |
|
||||
Total VitaCup, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Whoop, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Consumer Products & Services ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
46
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Education Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Medical Sales Training Holding Company |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Yellowbrick Learning, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Education Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Finance and Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
DailyPay, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dynamics, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Empower Financial, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Eqis Capital Management, Inc. |
|
Warrant |
|
|
|
Preferred Class B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Petal Card, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Petal Card, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
RealtyMogul, Co. |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Slope Tech, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Slope Tech, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
ZenDrive, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Finance and Insurance ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Food and Agriculture Technologies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Athletic Brewing Company, LLC |
|
Warrant |
|
|
|
Preferred Class B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Bowery Farming, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Bowery Farming, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Daring Foods, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
DrinkPak, LLC |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total DrinkPak, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Emergy, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GrubMarket, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Intelligent Brands, Inc. (f.k.a. PSB Holdings, Inc.) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Intelligent Brands, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
The Fynder Group, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Zero Acre Farms, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Food and Agriculture Technologies ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
47
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Green Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Bolb, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Edeniq, Inc. |
|
Warrant(11) |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
— |
|
|
|
|
|||||
|
|
Warrant(11) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Edeniq, Inc.(20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Footprint International Holding, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
Total Footprint International Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Mainspring Energy, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Mainspring Energy, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
RTS Holding, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total RTS Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Green Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Healthcare Technology ** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dentologie Enterprises, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Exer Holdings, LLC |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Hospitalists Now, Inc. |
|
Warrant |
|
|
|
Preferred Series D-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series D-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Hospitalists Now, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Lark Technologies, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Lark Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Moxe Health Corporation |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
RXAnte, Inc. |
|
Warrant(9) |
|
|
|
Preferred A |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred A |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant(9) |
|
|
|
Preferred A |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total RXAnte, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
TMRW Life Sciences, Inc. |
|
Warrant |
|
|
|
Preferred Class A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Class A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total TMRW Life Sciences, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Healthcare Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Human Resource Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
BetterLeap, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Qwick, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Human Resource Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
48
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
3DEO, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
SBG Labs, Inc. |
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total SBG Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-total: Industrials ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Marketing, Media, and Entertainment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Drone Racing League, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Firefly Systems, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Grabit Interactive Media, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Incontext Solutions, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
PebblePost, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Marketing, Media, and Entertainment ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Medical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Convergent Dental, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Delphinus, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series E⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Neuros Medical, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revelle Aesthetics, Inc. |
|
Warrant |
|
|
|
Preferred Series A-2⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Shoulder Innovations, Inc. |
|
Warrant(9) |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Medical Devices ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
49
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Real Estate Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Homelight, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Knockaway, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
— |
|
|||||
|
|
Warrant⁽¹¹⁾ |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
— |
|
|
|
— |
|
||||
Total Knockaway, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Maxwell Financial Labs, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Maxwell Financial Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Real Estate Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
SaaS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
All Seated, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cart.com, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Crowdtap, Inc. |
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Crowdtap, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Gtxcel, Inc. |
|
Warrant |
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Gtxcel, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Lucidworks, Inc. |
|
Warrant |
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Reciprocity, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Reciprocity, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Smartly, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
The Tomorrow Companies, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: SaaS ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
50
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Astranis Space Technology Corporation |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Axiom Space, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
|
|
|
|
|
||||||
Total Axiom Space, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Hermeus Corporation |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Rocket Lab USA, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Space Perspective, Inc. |
|
Warrant |
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Space Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Macrofab, Inc. |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Supply Chain Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Transportation Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Get Spiffy, Inc. |
|
Warrant(9) |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
NextCar Holding Company, Inc. |
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
|
|
Warrant |
|
|
|
Preferred Stock(17) |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
Total NextCar Holding Company, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Transportation Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- United States ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
51
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Expiration Date |
|
Series |
|
Shares |
|
|
Strike Price |
|
|
Cost |
|
|
Fair Value (6) |
|
||||
Warrant Investments- Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Nexii Building Solutions, Inc.(10) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
(13) |
$ |
|
(13) |
$ |
|
|
$ |
— |
|
|||||
|
|
Warrant |
|
|
|
Common Stock |
|
|
|
(13) |
$ |
|
(13) |
|
|
|
|
— |
|
|||||
Total Nexii Building Solutions, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- Canada ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Warrant Investments- Europe |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Aledia, Inc.(10) |
|
Warrant |
|
|
|
Preferred Series D-3⁽¹⁷⁾ |
|
|
|
(13) |
$ |
|
(13) |
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Information ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
All.Space Networks, Limited.(10) |
|
Warrant |
|
|
|
Common Stock |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sub-Total: Space Technology ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- Europe ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total: Warrant Investments- ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
52
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Shares / Principal |
|
|
Series |
|
Cost |
|
|
Fair Value (6) |
|
|||
Equity Investments- United States |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Artificial Intelligence & Automation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rigetti & Co, Inc. |
|
Equity(7) |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
|
||||
|
|
Equity(7) |
|
|
|
|
|
Common Stock |
|
|
|
|
|
|
||||
Total Rigetti & Co, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Artificial Intelligence & Automation ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Connectivity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Tarana Wireless, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series 6⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Vertical Communications, Inc. |
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series 1⁽¹⁷⁾ |
|
$ |
— |
|
|
$ |
— |
|
||
|
|
Equity |
|
|
$ |
|
|
Convertible Note⁽¹⁶⁾ |
|
|
|
|
|
|
||||
Total Vertical Communications, Inc.(20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Connectivity ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Project Frog, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series AA-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series BB⁽¹⁷⁾ |
|
|
|
|
|
— |
|
|||
|
|
Equity |
|
|
|
|
|
Common Stock |
|
|
|
|
|
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series CC⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total Project Frog, Inc.(20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Consumer Products & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Molekule, Inc. |
|
Equity(7) |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Portofino Labs, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Quip NYC, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Consumer Products & Services ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Finance and Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dynamics, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series A⁽¹⁷⁾ |
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Openly Holdings Corp. |
|
Equity |
|
|
|
|
|
Series D |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Slope Tech, Inc. |
|
Equity |
|
|
|
|
|
Preferred ⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Finance and Insurance ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Food and Agriculture Technologies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emergy, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Intelligent Brands, Inc. (f.k.a. Pruvit Ventures, Inc.) |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Food and Agriculture Technologies ( |
|
|
|
|
$ |
|
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Green Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Edeniq, Inc. |
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
— |
|
|
$ |
|
|||
|
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
|
— |
|
|
|
|
|||
|
|
Equity⁽¹¹⁾ |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
|
— |
|
|
|
|
|||
Total Edeniq, Inc.(20) |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Electric Hydrogen Co. |
|
Equity |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Mainspring Energy, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series E-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
RTS Holding, Inc. |
|
Equity(9) |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity(9) |
|
|
|
|
|
Preferred Series D-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total RTS Holding, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Green Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
53
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Shares / Principal |
|
|
Series |
|
Cost |
|
|
Fair Value (6) |
|
|||
Equity Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Healthcare Technology ** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Dentologie Enterprises, Inc. |
|
Equity(9) |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Emerald Cloud Lab, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Lark Technologies, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
WorkWell Prevention & Care Inc. |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series P⁽¹⁷⁾ |
|
|
|
|
|
— |
|
|||
|
|
Equity |
|
|
$ |
|
|
Convertible Note⁽¹⁶⁾ |
|
|
|
|
|
— |
|
|||
Total WorkWell Prevention & Care Inc.(20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Healthcare Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Human Resource Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nomad Health, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series D-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Human Resource Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Industrials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SBG Labs, Inc. |
|
Equity(7) |
|
|
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity(7) |
|
|
|
|
|
Preferred Series A-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total SBG Labs, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Industrials ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Multi-Sector Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Senior Credit Corp 2022 LLC(10)(20) |
|
Equity(7) |
|
|
|
— |
|
|
Preferred ⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Multi-Sector Holdings ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Real Estate Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Knockaway, Inc. |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
Equity |
|
|
|
|
|
Preferred Series AA⁽¹⁷⁾ |
|
|
|
|
|
— |
|
|||
Total Knockaway Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Orchard Technologies, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series D⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity |
|
|
|
|
|
Preferred Series 1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total Orchard Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Maxwell Financial Labs, Inc |
|
Equity |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Real Estate Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
54
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
Portfolio Company (1) |
|
Type of |
|
Investment Date (3) |
|
Shares / Principal |
|
|
Series |
|
Cost |
|
|
Fair Value (6) |
|
|||
Equity Investments- United States, Continued |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
SaaS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Smartly, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series B⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
The Tomorrow Companies, Inc. |
|
Equity(9) |
|
|
|
|
|
Preferred Series E-1⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: SaaS ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Space Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Astranis Space Technology Corporation |
|
Equity(9) |
|
|
|
|
|
Preferred Series C Prime⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Axiom Space, Inc. |
|
Equity |
|
|
|
|
|
Preferred Series C⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Hadrian Automation, Inc. |
|
Equity |
|
|
|
|
|
Preferred A-4⁽¹⁷⁾ |
|
$ |
|
|
$ |
|
||||
|
|
Equity(9) |
|
|
|
|
|
Preferred B-1⁽¹⁷⁾ |
|
|
|
|
|
|
||||
Total Hadrian Automation, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Space Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Supply Chain Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
3Q GoFor Holdings, LP(21) |
|
Equity⁽¹⁴⁾ |
|
|
|
— |
|
|
Preferred ⁽¹⁷⁾ |
|
$ |
|
|
$ |
— |
|
||
|
|
Equity⁽¹⁴⁾ |
|
|
|
— |
|
|
Preferred ⁽¹⁷⁾ |
|
|
|
|
|
— |
|
||
Total 3Q GoFor Holdings, LP(21) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-total: Supply Chain Technology ( |
|
|
|
|
|
$ |
|
|
$ |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Equity Investments- United States ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Equity Investments- Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Construction Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Nexii Building Solutions, Inc.(10) |
|
Equity |
|
|
|
|
|
Common Stock |
|
$ |
|
|
$ |
— |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sub-Total: Construction Technology ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Equity Investments- Canada ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total: Equity Investments ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total Investment in Securities ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cash and Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Goldman Sachs Financial Square Government Institutional Fund |
|
|
|
|
|
$ |
|
|
$ |
|
||||||||
Other cash accounts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Cash and Cash Equivalents ( |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Total Portfolio Investments and Cash and Cash Equivalents ( |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
*
**
55
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
56
TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2023
(In thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in |
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|||||||
|
|
Fair Value at |
|
|
Gross |
|
|
Gross |
|
|
Realized |
|
|
(Depreciation)/ |
|
|
Fair Value at |
|
|
Interest and |
|
|||||||
|
|
December 31, 2022 |
|
|
Additions (1) |
|
|
Reductions (2) |
|
|
Gain/(Loss) |
|
|
Appreciation |
|
|
December 31, 2023 |
|
|
Dividend Income |
|
|||||||
For the Year Ended December 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Control Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Edeniq, Inc. |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
||||
3Q GoFor Holdings, LP |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
|||
Project Frog, Inc. |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
||
Vertical Communications, Inc. |
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
|
||||
WorkWell Prevention and Care Inc. |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|||
Total Control Investments |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Affiliate Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
FemTec Health, Inc. |
|
$ |
|
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
||
Senior Credit Corp 2022 LLC |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
||||
Total Affiliate Investments |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Total Control and Affiliate Investments |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
57
TRINITY CAPITAL INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Note 1. Organization and Basis of Presentation
Trinity Capital Inc. (“Trinity Capital” and, together with its subsidiaries, the “Company”) is a specialty lending company focused on providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company (“BDC”).
Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Trinity Capital has elected to be treated, currently qualifies, and intends to continue to qualify annually as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), for U.S. federal income tax purposes.
On September 27, 2019, Trinity Capital was initially capitalized with the issuance of
On January 16, 2020, Trinity Capital completed a private offering of shares of its common stock (the “Private Common Stock Offering”) pursuant to which it issued and sold
Concurrent with the initial closing of the Private Common Stock Offering, the Company completed a private debt offering (the “144A Note Offering” and together with the Private Common Stock Offering, the “Private Offerings”), pursuant to which it issued and sold $
On January 16, 2020, Trinity Capital completed a series of transactions, the Private Offerings, and the acquisition of Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively, the “Legacy Funds”) through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital’s acquisition of Trinity Capital Holdings, LLC (“Trinity Capital Holdings”) (collectively, the “Formation Transactions”).
Trinity Capital’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN” in connection with its initial public offering of shares of its common stock (“IPO”).
Basis of Presentation
The Company’s interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period’s consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (“SEC”) on March 6, 2024. As an investment company, the Company follows accounting and reporting guidance determined by the Financial
58
Accounting Standards Board (“FASB”), in Accounting Standards Codification, as amended (“ASC”) 946, Financial Services – Investment Companies (“ASC 946”).
Principles of Consolidation
Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 3 - Investments,” with any adjustments to fair value recognized as “Net unrealized appreciation/(depreciation) from investments” on the Consolidated Statements of Operations.
The Company’s consolidated operations include the activities of its wholly owned subsidiaries, Trinity Funding 1, LLC (“TF1”), and TrinCap Funding, LLC (“TCF”). TF1 was formed on August 14, 2019, as a Delaware limited liability company with Fund II as its sole equity member. On January 16, 2020, in connection with the Formation Transactions, Trinity Capital acquired TF1 through Fund II and became a party to, and assumed, a $
In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, the Company must determine which of its unconsolidated controlled subsidiaries, if any, are considered “significant subsidiaries.” In evaluating these unconsolidated controlled subsidiaries, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of the Company’s investments or unconsolidated controlled subsidiaries are considered significant: the investment test and the income test. As of March 31, 2024 and December 31, 2023, none of the Company’s investments or unconsolidated controlled subsidiaries met either of these two significance tests.
Senior Credit Corp 2022 LLC
On December 5, 2022, the Company entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager (collectively, the “JV Partner”) to co-manage Senior Credit Corp 2022 LLC (the “JV”). The JV invests in secured loans and equipment financings to growth-stage companies that have been originated by the Company. The Company and the JV Partner committed to initially contribute $
The Company has agreed to offer the JV the opportunity to purchase up to
59
financing advance acquired by the JV from the Company, with
As permitted under Regulation S-X and consistent with the guidance in ASC 946-810-45-3, the Company will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. As the Company’s representatives do not comprise the majority of the board of managers of the JV and the Company does not hold a majority of the economic interests in the JV, the Company does not consolidate the JV in its financial statements.
As of March 31, 2024, the Company contributed $
As of March 31, 2024 and December 31, 2023, the JV's total investment portfolio on a fair value basis was $
During the three months ended March 31, 2024 and March 31, 2023, the Company earned approximately $
Note 2. Summary of Significant Accounting Policies
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from these estimates.
Investment Transactions
Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.
Valuation of Investments
The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.
60
The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.
The SEC adopted Rule 2a-5 under the 1940 Act (“Rule 2a-5”), which establishes a framework for determining fair value in good faith for purposes of the 1940 Act. As adopted, Rule 2a-5 permits boards of directors to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. The SEC also adopted Rule 31a-4 under the 1940 Act (“Rule 31a-4”), which provides the recordkeeping requirements associated with fair value determinations. While the Company's Board has not elected to designate a valuation designee, the Company has adopted certain revisions to its valuation policies and procedures to comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.
While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms, on a discretionary basis, to provide the Company with valuation assistance with respect to its investments. Specifically, on a quarterly basis, the Company identifies portfolio investments with respect to which an independent valuation firm assists in valuing such investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.
Investments recorded on the Company’s Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:
Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).
Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.
Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.
Given the nature of lending to venture capital-backed growth-stage companies,
61
Debt Securities
The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth-stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.
In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.
Equity Securities and Warrants
Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company generally utilizes a combination of one or several forms of the market approach and contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.
Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables, and other liabilities, approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.
Cash and Cash Equivalents
Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (
62
risk of loss associated with any uninsured balances is remote. As of March 31, 2024 and December 31, 2023, the Company did not have any restricted cash.
Other Assets
Other assets generally consist of fixed assets net of accumulated depreciation, leasehold improvements net of accumulated depreciation, right-of-use assets, prepaid expenses, escrow receivables, deferred offering costs, and security deposits for operating leases.
Escrow Receivables
Escrow receivables are collected in accordance with the terms and conditions of the escrow agreement. Escrow balances are typically distributed over a period of
Equity Offering Costs
Equity offering costs consist of fees and costs incurred in connection with the sale of the Company’s common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Equity offering costs are periodically reviewed and expensed if the related registration is no longer active.
Security Deposits
Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.
Debt Financing Costs
The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations. Debt financing costs related to secured or unsecured notes are netted with the outstanding principal balance on the Company’s Consolidated Statements of Assets and Liabilities. Debt financing costs related to the KeyBank Credit Facility are recorded as a separate asset on the Company’s Consolidated Statements of Assets and Liabilities.
Income Recognition
Interest and Dividend Income
The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) payment. EOT payments to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT payment is recognized as interest income.
The Company has a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan
63
balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. The Company recorded $
Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, is amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT payment received in consideration for contract modifications commencing in the quarter relating to the specific modification.
The Company records dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution. The Company recorded $
Fee and Other Income
The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity. In addition, fee income may include fees for originations and administrative agent services rendered by the Company to the JV. Such fees are earned in the period that the services are rendered.
Non-Accrual Policy
When a debt security becomes
As of March 31, 2024, loans to
Net Realized Gains / (Losses)
Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statements of Operations.
64
Net Unrealized Appreciation / (Depreciation)
Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.
Stock-Based Compensation
The Company has issued and may, from time to time, issue restricted stock to its officers and employees under the 2019 Trinity Capital Inc. Long Term Incentive Plan and to its non-employee directors under the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan. The Company accounts for its stock-based compensation plans using the fair value method, as prescribed by ASC 718, Compensation – Stock Compensation. Accordingly, for restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the date of the grant and amortizes the fair value of the awards as stock-based compensation expense over the requisite service period, which is generally the vesting term.
The Company has also adopted Accounting Standards Update (“ASU”) 2016-09, Compensation—Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which requires that all excess tax benefits and tax deficiencies (including tax benefits of dividends on stock-based payment awards) be recognized as income tax expense or benefit in the income statement and not delay recognition of a tax benefit until the tax benefit is realized through a reduction to taxes payable. Accordingly, the tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. Additionally, the Company has elected to account for forfeitures as they occur.
Earnings Per Share
The Company's earnings per share (“EPS”) amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of common shares outstanding for the period. In accordance with ASC 260, Earnings Per Share, the unvested shares of restricted stock awarded pursuant to Trinity Capital’s equity compensation plans are participating securities and, therefore, are included in the basic earnings per share calculation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued and the additional shares of common stock were dilutive. Diluted EPS, if any, reflects the potential dilution from the assumed conversion of the Company’s
Income Taxes
The Company has elected to be treated, currently qualifies, and intends to continue to qualify annually as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least the sum of
The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC 740, Income Taxes (“ASC 740”), as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has
65
Based on federal excise distribution requirements applicable to RICs, the Company will be subject to a
Distributions
Distributions to common stockholders are recorded on the record date. The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders.
Note 3. Investments
The Company provides debt, including loans and equipment financings, to growth-stage companies, including venture capital-backed companies and companies with institutional equity investors, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity, and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of its portfolio companies.
Debt Securities
The Company’s debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission-critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between and
The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company’s second lien positions.
Warrant Investments
In connection with the Company’s debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract
66
price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.
Equity Investments
In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in its portfolio companies of
Portfolio Composition
The Company’s portfolio investments are in companies conducting business in a variety of industries. Industry classifications have been updated to a preferred presentation and the prior year has been amended to conform with the new preferred presentation.
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||||||||||||||||||
|
|
Cost |
|
|
Fair Value |
|
|
Cost |
|
|
Fair Value |
|
||||||||||||||||||||
Industry |
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
||||||||
Finance and Insurance |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
||||||||
Green Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Space Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Consumer Products & Services |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Real Estate Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Healthcare Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Food and Agriculture Technologies |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Medical Devices |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Artificial Intelligence & Automation |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Biotechnology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
SaaS |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Marketing, Media, and Entertainment |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Diagnostics & Tools |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||||
Education Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Connectivity |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Human Resource Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Transportation Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Supply Chain Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Digital Assets Technology and Services |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Industrials |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Multi-Sector Holdings (1) |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Construction Technology |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Total |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
67
The geographic composition of the Company's investment portfolio is determined by the location of the corporate headquarters of the portfolio company.
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||||||||||||||||||
|
|
Cost |
|
|
Fair Value |
|
|
Cost |
|
|
Fair Value |
|
||||||||||||||||||||
Geographic Region |
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
||||||||
United States: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
West |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
||||||||
Northeast |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
South |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Mountain |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Southeast |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Midwest |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Senior Credit Corp 2022 LLC (1) |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
International: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Western Europe |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Canada |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Total |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
The following table summarizes the composition of the Company’s portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of March 31, 2024 and December 31, 2023 (dollars in thousands):
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||||||||||||||||||
|
|
Cost |
|
|
Fair Value |
|
|
Cost |
|
|
Fair Value |
|
||||||||||||||||||||
Investment |
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
|
Amount |
|
|
% |
|
||||||||
Secured Loans |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
||||||||
Equipment Financing |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Warrants |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Equity |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
|
|
|
|
|
% |
||||||||
Total |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
|
$ |
|
|
|
% |
Certain Risk Factors
In the ordinary course of business, the Company manages a variety of risks, including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including investment limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.
Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks.
68
The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.
The Company’s investments are generally comprised of securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.
The Company’s investments consist of growth-stage companies, many of which have relatively limited operating histories and may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by changes in government regulations. Most of the Company’s borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.
Note 4. Fair Value of Financial Instruments
ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. The Company accounts for its investments at fair value in accordance with ASC 820. As of March 31, 2024 and December 31, 2023, the Company’s portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported.
In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See “Note 2 – Summary of Significant Accounting Policies.”
As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
The fair value determination of each portfolio investment categorized as Level 3 requires one or more of the following unobservable inputs:
69
The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company’s investments, are (i) earnings before interest, tax, depreciation, and amortization (“EBITDA”) and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. Conversely, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.
The Company’s assets measured at fair value by investment type on a recurring basis as of March 31, 2024 were as follows (in thousands):
|
|
Fair Value Measurements at Reporting Date Using |
|
|
|
|
|
|
|
|||||||||||
|
|
Quoted Prices |
|
|
Significant |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
in Active |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
|
|||||
|
|
Markets for |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
|
|||||
|
|
Identical Assets |
|
|
Inputs |
|
|
Inputs |
|
|
Measured at |
|
|
|
|
|||||
Assets |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Net Asset Value(1) |
|
|
Total |
|
|||||
Secured Loans |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||
Equipment Financings |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Warrants |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||
Equity |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
||||
Total Investments at fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Escrow Receivable (2) |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
70
The Company’s assets measured at fair value by investment type on a recurring basis as of December 31, 2023 were as follows (in thousands):
|
|
Fair Value Measurements at Reporting Date Using |
|
|
|
|
|
|
|
|||||||||||
|
|
Quoted Prices |
|
|
Significant |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
in Active |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
|
|||||
|
|
Markets for |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
|
|||||
|
|
Identical Assets |
|
|
Inputs |
|
|
Inputs |
|
|
Measured at |
|
|
|
|
|||||
Assets |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Net Asset Value(1) |
|
|
Total |
|
|||||
Secured Loans |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||
Equipment Financings |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Warrants |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||
Equity |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
||||
Total Investments at fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Escrow Receivable (2) |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The methodology for determining the fair value of the Company’s investments is discussed in “Note 2 – Summary of Significant Accounting Policies”. The significant unobservable input used in the fair value measurement of the Company’s escrow receivables is the amount recoverable at the contractual maturity date of the escrow receivable.
|
|
Fair Value as of |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
March 31, 2024 |
|
|
Valuation Techniques/ |
|
Unobservable |
|
|
|
Weighted |
|
|
||
Investment Type |
|
(in thousands) |
|
|
Methodologies |
|
Inputs (1) |
|
Range |
|
Average (2) |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Debt investments |
|
$ |
|
|
Discounted Cash Flows |
|
Hypothetical Market Yield |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Cost approximates fair value (6) |
|
n/a |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Scenario Analysis |
|
Probability Weighting of Alternative Outcomes |
|
|
n/a |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Debt investment in the JV |
|
|
|
|
Enterprise Value (7) |
|
n/a |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Equity investments |
|
|
|
|
Market Approach |
|
Revenue Multiple (3) |
|
|
|
|
x |
|||
|
|
|
|
|
|
|
Volatility (5) |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
Risk-Free Interest Rate |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
Estimated Time to Exit (in years) |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Warrants |
|
|
|
|
Market Approach |
|
Revenue Multiple (3) |
|
|
|
|
x |
|||
|
|
|
|
|
|
|
Company Specific Adjustment (4) |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
Volatility (5) |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
Risk-Free Interest Rate |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
Estimated Time to Exit (in years) |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Total Level 3 Investments |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
71
The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, 2023.
|
|
Fair Value as of |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
December 31, 2023 |
|
|
Valuation Techniques/ |
|
Unobservable |
|
|
|
Weighted |
|
|
|||
Investment Type |
|
(in thousands) |
|
|
Methodologies |
|
Inputs (1) |
|
Range |
|
Average (2) |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Debt investments |
|
$ |
|
|
|
Discounted Cash Flows |
|
Hypothetical Market Yield |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Cost approximates fair value (6) |
|
n/a |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Transaction Precedent (7) |
|
Transaction Price |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Scenario Analysis |
|
Probability Weighting of Alternative Outcomes |
|
|
n/a |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Debt investment in the JV |
|
|
|
|
|
Enterprise Value (8) |
|
n/a |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Equity investments |
|
|
|
|
|
Market Approach |
|
Revenue Multiple (3) |
|
|
|
|
x |
|||
|
|
|
|
|
|
|
|
Volatility (5) |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
|
Risk-Free Interest Rate |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
|
Estimated Time to Exit (in years) |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Warrants |
|
|
|
|
|
Market Approach |
|
Revenue Multiple (3) |
|
|
|
|
x |
|||
|
|
|
|
|
|
|
|
Company Specific Adjustment (4) |
|
n/a |
|
n/a |
|
|
||
|
|
|
|
|
|
|
|
Volatility (5) |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
|
Risk-Free Interest Rate |
|
|
|
|
% |
|||
|
|
|
|
|
|
|
|
Estimated Time to Exit (in years) |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Total Level 3 Investments |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
72
The following table provides a summary of changes in the fair value of the Company’s Level 3 debt, including loans and equipment financings (collectively “Debt”), equity, warrant and escrow receivable portfolio investments for the three months ended March 31, 2024 (in thousands):
|
|
Type of Investment |
|
|||||||||||||||||
|
|
Debt |
|
|
Equity |
|
|
Warrants |
|
|
Escrow Receivable |
|
|
Total |
|
|||||
Fair Value as of December 31, 2023 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Purchases, net of deferred fees |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||
Non-cash conversions (1) |
|
|
— |
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
Transfers into/(out of) Level 3 (2) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Proceeds from sales and paydowns |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Accretion of OID, EOT, and PIK payments |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Net change in unrealized appreciation/(depreciation) |
|
|
( |
) |
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) |
||
Fair Value as of March 31, 2024 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net change in unrealized appreciation/depreciation on Level 3 investments still held as of March 31, 2024 |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
( |
) |
73
The following table provides a summary of changes in the fair value of the Company’s Level 3 debt, including loans and equipment financings (collectively “Debt”), equity, and warrant portfolio investments for the year ended December 31, 2023 (in thousands):
|
|
Type of Investment |
|
|||||||||||||||||
|
|
Debt |
|
|
Equity |
|
|
Warrants |
|
|
Escrow Receivable |
|
|
Total |
|
|||||
Fair Value as of December 31, 2022 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Purchases, net of deferred fees |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||
Non-cash conversion (1) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
|
||
Transfers into/(out of) of Level 3 (2) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Proceeds from sales and paydowns |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Accretion of OID and EOT payments |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
— |
|
|
|
( |
) |
||
Change in unrealized appreciation/(depreciation) |
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
|
|||
Fair Value as of December 31, 2023 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net change in unrealized appreciation/depreciation on Level 3 investments still held as of December 31, 2023 |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
( |
) |
Fair Value of Financial Instruments Carried at Cost
As of March 31, 2024 and December 31, 2023, the carrying value of the KeyBank Credit Facility was approximately $
As of March 31, 2024 and December 31, 2023, the carrying value of the 2025 Notes was approximately $
As of March 31, 2024 and December 31, 2023, the carrying value of the Convertible Notes was approximately $
As of March 31, 2024 and December 31, 2023, the carrying value of the
As of March 31, 2024, and December 31, 2023, the carrying value of the Company’s
74
deferred financing fees of $
As of March 31, 2024, the carrying value of the Company's
Note 5. Borrowings
KeyBank Credit Facility
On October 27, 2021, TCF, a wholly owned subsidiary of the Company, as borrower, and the Company, as servicer, entered into a credit agreement (as amended, the “KeyBank Credit Agreement”) with the lenders from time-to-time party thereto, KeyBank, as administrative agent and syndication agent, and Wells Fargo, National Association, as collateral custodian and paying agent.
The KeyBank Credit Facility includes a commitment of $
The KeyBank Credit Facility includes a
The KeyBank Credit Agreement also contains customary events of default (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.
During the three months ended March 31, 2024, the Company borrowed $
The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):
75
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
||
|
|
March 31, 2024 |
|
|
|
|
March 31, 2023 |
|
|
|
||
Stated interest expense |
$ |
|
|
|
|
$ |
|
|
|
|
||
Amortization of deferred financing costs |
|
|
|
|
|
|
|
|
|
|
||
Total interest and amortization of deferred financing costs |
$ |
|
|
|
|
$ |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
||
Weighted average effective interest rate |
|
|
|
% |
|
|
|
|
% |
|
||
Weighted average outstanding balance |
$ |
|
|
|
|
$ |
|
|
|
|
2025 Notes
Concurrent with the completion of the Private Common Stock Offering, on January 16, 2020, the Company completed its offering of $
Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.
The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (together with its successor in interest, U.S. Bank Trust Company, National Association, the “Trustee”), and a First Supplemental Indenture, dated as of January 16, 2020 (the “First Supplemental Indenture” and together with the Base Indenture, the “2025 Notes Indenture”), between the Company and the Trustee. The 2025 Notes mature on
On July 22, 2022, the Company issued $
In connection with the additional issuance of the 2025 Notes, the 2025 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINL” on July 29, 2022.
76
Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriters' discount and commissions, were approximately $
The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
||
|
|
|
March 31, 2024 |
|
|
|
|
March 31, 2023 |
|
|
|
||
Stated interest expense |
|
$ |
|
|
|
|
$ |
|
|
|
|
||
Amortization of deferred financing costs |
|
|
|
|
|
|
|
|
|
|
|
||
Total interest and amortization of deferred financing costs |
|
$ |
|
|
|
|
$ |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Weighted average effective interest rate |
|
|
|
|
% |
|
|
|
|
% |
|
||
Weighted average outstanding balance |
|
$ |
|
|
|
|
$ |
|
|
|
|
On August 24, 2021, the Company issued and sold $
Aggregate offering costs in connection with the August 2026 Notes issuance, including the underwriters’ discount and commissions, were approximately $
77
March 31, 2024 and December 31, 2022, unamortized deferred financing costs related to the August 2026 Notes were $
The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
||
|
|
|
March 31, 2024 |
|
|
|
|
March 31, 2023 |
|
|
|
||
Stated interest expense |
|
$ |
|
|
|
|
$ |
|
|
|
|
||
Amortization of deferred financing costs |
|
|
|
|
|
|
|
|
|
|
|
||
Total interest and amortization of deferred financing costs |
|
$ |
|
|
|
|
$ |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Weighted average effective interest rate |
|
|
|
|
% |
|
|
|
|
% |
|
||
Weighted average outstanding balance |
|
$ |
|
|
|
|
$ |
|
|
|
|
March 2029 Notes
On March 28, 2024, the Company issued and sold $
The March 2029 Notes were issued pursuant to the Base Indenture and a Fifth Supplemental Indenture, dated as of March 28, 2024 (together with the Base Indenture, the “March 2029 Notes Indenture”), between the Company and the Trustee. The March 2029 Notes mature on
Aggregate offering costs in connection with the March 2029 Notes issuance, including the underwriters’ discount and commissions, were approximately $
The components of interest expense and related fees for the March 2029 Notes are as follows (in thousands):
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
||
|
|
|
March 31, 2024 |
|
|
|
|
March 31, 2023 |
|
|
|
||
Stated interest expense |
|
$ |
|
|
|
|
$ |
|
— |
|
|
|
|
Amortization of deferred financing costs |
|
|
|
|
|
|
|
|
— |
|
|
|
|
Total interest and amortization of deferred financing costs |
|
$ |
|
|
|
|
$ |
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Weighted average effective interest rate |
|
|
|
|
% |
|
|
|
— |
|
% |
|
|
Weighted average outstanding balance |
|
$ |
|
|
|
|
$ |
|
— |
|
|
|
78
December 2026 Notes
On December 15, 2021, the Company issued and sold $
Aggregate offering costs in connection with the December 2026 Notes issuance, including the underwriters’ discount and commissions, were approximately $
The components of interest expense and related fees for the December 2026 Notes are as follows (in thousands):
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
||
|
|
|
March 31, 2024 |
|
|
|
|
March 31, 2023 |
|
|
|
||
Stated interest expense |
|
$ |
|
|
|
|
$ |
|
|
|
|
||
Amortization of deferred financing costs |
|
|
|
|
|
|
|
|
|
|
|
||
Total interest and amortization of deferred financing costs |
|
$ |
|
|
|
|
$ |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Weighted average effective interest rate |
|
|
|
|
% |
|
|
|
|
% |
|
||
Weighted average outstanding balance |
|
$ |
|
|
|
|
$ |
|
|
|
|
6.00% Convertible Notes due 2025
On December 11, 2020, the Company completed a private offering (the “Private Convertible Note Offering”) of $
The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the “Second Supplemental Indenture” and together with the Base Indenture, the
79
“Convertible Notes Indenture”), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof. Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $
Holders may convert their Convertible Notes, at their option, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date. The conversion rate was initially
At the Company’s option, it may cause holders to convert all or a portion of the then outstanding principal amount of the Convertible Notes plus accrued but unpaid interest, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date, if the closing sale price of the Company’s common stock for any
In addition, if the Company undergoes a fundamental change (as defined in the Second Supplemental Indenture), holders may require the Company to repurchase for cash all or part of such holders’ Convertible Notes at a repurchase price equal to
The Convertible Notes are direct unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated, and senior in right of payment to all of the Company’s future indebtedness or other obligations that are expressly subordinated, or junior, in right of payment to the Convertible Notes.
The Convertible Notes are accounted for in accordance with ASC 470-20, Debt Instruments with Conversion and Other Options. In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately
80
The components of the carrying value of the Convertible Notes were as follows (in thousands):
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
||||
Principal amount of debt |
|
$ |
|
|
|
$ |
|
|
||
Unamortized debt financing cost |
|
|
|
( |
) |
|
|
|
( |
) |
Original issue discount, net of accretion |
|
|
|
( |
) |
|
|
|
( |
) |
Carrying value of Convertible Notes |
|
$ |
|
|
|
$ |
|
|
The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):
|
|
|
Three Months Ended |
|
|
|
Three Months Ended |
|
|
||
|
|
|
March 31, 2024 |
|
|
|
March 31, 2023 |
|
|
||
Stated interest expense |
|
$ |
|
|
|
$ |
|
|
|
||
Amortization of deferred financing costs and original issue discount |
|
|
|
|
|
|
|
|
|
||
Total interest and amortization of deferred financing costs and original issue discount |
|
$ |
|
|
|
$ |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
Weighted average effective interest rate |
|
|
|
|
% |
|
|
|
% |
||
Weighted average outstanding balance |
|
$ |
|
|
|
$ |
|
|
|
As of March 31, 2024 and December 31, 2023, the Company was in compliance with the terms of the KeyBank Credit Agreement, the 2025 Notes Indenture, the August 2026 Notes Indenture, the December 2026 Notes Indenture, the March 2029 Notes Indenture and the Convertible Notes Indenture.
Note 6. Commitments and Contingencies
Unfunded Commitments
The Company’s commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of March 31, 2024 and December 31, 2023 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments as of March 31, 2024 and December 31, 2023 includes only those commitments that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions. As of March 31, 2024 and December 31, 2023, the Company had unfunded commitments of $
The Company did not have any other off-balance sheet financings or liabilities as of March 31, 2024 or December 31, 2023. The Company will fund its unfunded commitments, if any, from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under its KeyBank Credit Facility) and maintains adequate liquidity to fund its unfunded commitments through these sources.
In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.
81
Leases
ASU No. 2016‑02, Leases (Topic 842) (“ASU 2016‑02”) requires that a lessee evaluate its leases to determine whether they should be classified as operating or finance leases. The Company identified significant operating leases for its headquarters in Phoenix, AZ and office space in San Diego, CA. The lease for the Company's Phoenix headquarters commenced on
The total lease expense incurred for the three months ended March 31, 2024 and 2023 was $
The following table shows future minimum payments under the Company’s operating leases as of March 31, 2024 (in thousands):
For the Years Ended December 31, |
|
Total |
|
|
2024 |
|
$ |
|
|
2025 |
|
|
|
|
2026 |
|
|
|
|
2027 |
|
|
|
|
2028 |
|
|
|
|
Thereafter |
|
|
|
|
Total |
|
$ |
|
Legal Proceedings
The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of March 31, 2024, there are no material legal matters or material litigation pending of which the Company is aware.
Note 7. Stockholders' Equity
The Company authorized
Private Common Stock Offerings
On January 16, 2020, the Company completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act. As a result, the Company issued and sold a total of
Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the certain of the investors in the Legacy Funds (the “Legacy Investors”) that received shares of its common stock in connection with the Formation Transactions that were not the Company’s directors, officers and
82
affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.
Formation Transactions
On January 16, 2020, immediately following the initial closings of the Private Offerings, the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. As consideration for the Legacy Funds, the Company issued
Initial Public Offering
On February 2, 2021, the Company completed its initial public offering of
ATM Program
On November 9, 2021, the Company established the “ATM Program”, pursuant to which the Company can issue and sell, from time to time, up to $
The Company generally uses net proceeds from the ATM Program to make investments in accordance with its investment objective and investment strategy and for general corporate purposes.
During the three months ended March 31, 2024, the Company issued and sold
During the year ended December 31, 2023, the Company issued and sold
Stock Repurchase Program
On November 14, 2022, the Company and its Board authorized a program for the purpose of repurchasing up to $
83
The Company did
Equity Offerings
On April 7, 2022, the Company issued
On August 18, 2022, the Company issued
On August 8, 2023, the Company issued
Distribution Reinvestment Plan
The Company’s amended and restated distribution reinvestment plan (“DRIP”) provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not “opted out” of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company’s common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company’s common stock on the valuation date determined for each distribution by the Board.
The Company’s DRIP is administered by its transfer agent on behalf of the Company’s record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company’s DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended March 31, 2024, the Company issued
84
Distributions
The following table summarizes distributions declared and/or paid by the Company since inception:
Declaration |
|
Type |
|
Record |
|
Payment |
|
Per Share |
|
|
|
|
|
|
$ |
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
Total |
|
$ |
|
Note 8. Equity Incentive Plans
2019 Long Term Incentive Plan
The Company’s Board adopted and approved the 2019 Trinity Capital Inc. Long Term Incentive Plan (the “2019 Long Term Incentive Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Long Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long Term Incentive Plan becoming effective on June 17, 2021. Under the 2019 Long Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be granted to certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”) in accordance with the SEC exemptive order the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long Term Incentive Plan. The Employee Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.
Subject to certain adjustments under the 2019 Long Term Incentive Plan, the maximum aggregate number of shares of the Company’s common stock authorized for issuance under the 2019 Long Term Incentive Plan is
85
For additional information regarding the 2019 Long Term Incentive Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 26, 2024.
|
|
Three Months Ended |
|
|
Weighted Average |
|
|
Three Months Ended |
|
|
Weighted Average |
|
||||
|
|
March 31, 2024 |
|
|
Grant Date Fair Value |
|
|
March 31, 2023 |
|
|
Grant Date Fair Value |
|
||||
Unvested as of Beginning of Period |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
Shares Granted |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
Shares Vested and Forfeited |
|
|
( |
) |
|
$ |
|
|
|
( |
) |
|
$ |
|
||
Unvested as of Ending of Period |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Fair Value of Granted Stock |
$ |
|
|
|
|
|
$ |
|
|
|
|
|
||||
Compensation cost recognized |
$ |
|
|
|
|
|
$ |
|
|
|
|
|
As of March 31, 2024, there was approximately $
2019 Restricted Stock Plan
The Company’s Board adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders. The 2019 Restricted Stock Plan became effective on June 17, 2021 and provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act) in accordance with the SEC Exemptive Order. The Non-Employee Director Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.
Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is
For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Report on Form 8-K, filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 26, 2024. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three months ended March 31, 2024 and 2023 (dollars in thousands).
86
|
|
Three Months Ended |
|
|
Weighted Average |
|
|
Three Months Ended |
|
|
Weighted Average |
|
||||
|
|
March 31, 2024 |
|
|
Grant Date Fair Value |
|
|
March 31, 2023 |
|
|
Grant Date Fair Value |
|
||||
Unvested as of Beginning of Period, |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
Shares Granted |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
Shares Vested and Forfeited |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
Unvested as of Ending of Period, |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Fair Value of Granted Stock |
$ |
|
— |
|
|
|
|
$ |
|
— |
|
|
|
|
||
Compensation cost recognized |
$ |
|
|
|
|
|
$ |
|
|
|
|
|
As of March 31, 2024, there was less than $
The following table sets forth the computation of the basic and diluted earnings per common share for the three months ended March 31, 2024 and 2023 (in thousands except shares and per share information):
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
||
Earnings per common share - basic |
|
|
|
|
|
|
||
Numerator for basic earnings per share |
|
$ |
|
|
$ |
|
||
Denominator for basic weighted average shares |
|
|
|
|
|
|
||
Earnings/(Loss) per common share - basic |
|
$ |
|
|
$ |
|
||
Earnings per common share - diluted |
|
|
|
|
|
|
||
Numerator for increase in net assets per share |
|
|
|
|
|
|
||
Adjustment for interest expense, fees, and deferred financing costs on Convertible Notes |
|
|
|
|
|
|
||
Numerator for diluted earnings per share |
|
|
|
|
|
|
||
Denominator for basic weighted average shares |
|
|
|
|
|
|
||
Adjustment for dilutive effect of Convertible Notes |
|
|
|
|
|
|
||
Denominator for diluted weighted average shares |
|
|
|
|
|
|
||
Earnings/(Loss) per common share - diluted |
|
$ |
|
|
$ |
|
In certain circumstances, at the Company's election, the Convertible Notes will be convertible into cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, which can be dilutive to common stockholders. Diluted earnings (loss) available to each share of common stock outstanding during the reporting period included any additional shares of common stock that would be issued if all potentially dilutive securities were exercised. In accordance with ASU 2020-06, the Company is required to disclose diluted EPS using the if-converted method that assumes conversion of convertible securities at the beginning of the reporting period and is intended to show the maximum dilution effect to common stockholders regardless of how the conversion can occur.
Note 10. Income Taxes
The Company has elected to be treated, currently qualifies, and intends to continue to qualify annually as, a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least the sum of
87
any). The Company generally will not be subject to U.S. federal income tax on these distributed amounts, but will pay U.S. federal income tax at corporate rates on any retained amounts.
The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by management of the Company. Net capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. In the event the Company’s taxable income (including any net capital gains) for a fiscal year falls below the amount of distributions declared and paid with respect to that year, however, a portion of the total amount of those distributions may be deemed a return of capital for tax purposes to the Company’s stockholders.
Because federal income tax regulations differ from GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future.
For the three months ended March 31, 2024 and 2023, $
The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of March 31, 2024 and December 31, 2023 (in thousands):
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||
Tax Cost of Investments (1) |
|
|
|
|
$ |
|
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||
Unrealized appreciation |
|
$ |
|
|
$ |
|
||
Unrealized depreciation |
|
|
( |
) |
|
|
( |
) |
Net unrealized appreciation/(depreciation) from investments |
|
$ |
( |
) |
|
$ |
( |
) |
88
Note 11. Financial Highlights
The following presents financial highlights (in thousands except share and per share information):
|
|
Three Months Ended |
|
|
|
Three Months Ended |
|
|
||
|
|
March 31, 2024 |
|
|
|
March 31, 2023 |
|
|
||
Per Share Data: (1) |
|
|
|
|
|
|
|
|
||
Net asset value, beginning of period |
|
$ |
|
|
|
$ |
|
|
||
|
|
|
|
|
|
|
|
|
||
Net investment income |
|
|
|
|
|
|
|
|
||
Net realized and unrealized gains/(losses) on investments (2) |
|
|
( |
) |
|
|
|
|
|
|
Net increase/(decrease) in net assets resulting from operations |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||
Offering costs |
|
|
( |
) |
|
|
|
— |
|
|
Effect of shares issued and repurchased (3) |
|
|
( |
) |
|
|
|
( |
) |
|
Distributions (4) |
|
|
( |
) |
|
|
|
( |
) |
|
Total increase/(decrease) in net assets |
|
|
( |
) |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
||
Net asset value, end of period |
|
$ |
|
|
|
$ |
|
|
||
|
|
|
|
|
|
|
|
|
||
Shares outstanding, end of period |
|
|
|
|
|
|
|
|
||
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
||
Total return based on net asset value (5)(9) |
|
|
|
% |
|
|
|
% |
||
Total return based on market value (6)(9) |
|
|
|
% |
|
|
|
% |
||
|
|
|
|
|
|
|
|
|
||
Ratio/Supplemental Data: |
|
|
|
|
|
|
|
|
||
Per share market value at end of period |
|
$ |
|
|
|
$ |
|
|
||
Net assets, end of period |
|
$ |
|
|
|
$ |
|
|
||
Ratio of total expenses to average net assets (10) |
|
|
|
% |
|
|
|
% |
||
Ratio of net investment income to average net assets (10) |
|
|
|
% |
|
|
|
% |
||
Ratio of interest and credit facility expenses to average net assets (10) |
|
|
|
% |
|
|
|
% |
||
Portfolio turnover rate (7)(9) |
|
|
|
% |
|
|
|
% |
||
Asset coverage ratio (8) |
|
|
|
% |
|
|
|
% |
89
Senior Securities
Information about the Company’s senior securities (including debt securities and other indebtedness) is shown in the following table as of March 31, 2024, and December 2023, 2022, 2021 and 2020. No senior securities were outstanding as of December 31, 2019.
Class and Period |
Total |
|
Asset |
|
|
Involuntary |
|
|
Average |
|
||||||
Credit Suisse Credit Facility |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
December 30, 2023(5) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
December 31, 2022(5) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2020 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
KeyBank Credit Facility |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2022 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2020 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
2025 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
|
|
|
|
|
|
— |
|
|
$ |
|
|||
December 31, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||
December 31, 2022 |
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2020 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Convertible Notes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2022 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2020 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
August 2026 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2022 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2020 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
December 2026 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
|
|
|
|
|
|
|
|
|
|
||||
December 31, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2022 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2020 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 2029 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
$ |
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2023 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
December 31, 2022 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
December 31, 2021 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
December 31, 2020 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total |
|
|
|
|
|
|
|
|
|
|
|
|
||||
March 31, 2024 (Unaudited) |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2022 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
||
December 31, 2021 |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
90
During the three months ended March 31, 2024 and the year ended December 31, 2023, certain related parties received distributions from the Company relating to their shares held. Refer to “Note 7 – Stockholder’s Equity” for further details on the Company’s DRIP and the distributions declared. During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company’s directors and executive officers and certain employees received restricted stock awards under the 2019 Long Term Incentive Plan and the 2019 Restricted Stock Plan. Refer to “Note 8 – Equity Incentive Plans” for further details on the Company’s stock-based compensation plans.
The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company’s directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.
The Company and its executives and directors are covered by directors and officers insurance. In addition, each of our directors and officers have entered into an indemnification agreement with us pursuant to which our directors and officers are indemnified by us to the maximum extent permitted by Maryland law subject to the restrictions of the 1940 Act.
On December 5, 2022, the Company and the JV Partner formed an unconsolidated joint venture to co-invest with the Company. Refer to “Note 1 – Organization and Basis of Presentation” for further details on the Company’s investment in the JV.
Note 13. Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). This change is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, allowing financial statement users to better understand the components of a segment's profit or loss and assess potential future cash flows for each reportable segment and the entity as a whole. The amendments expand a public entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM“), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures and providing new disclosure requirements for entities with a single reportable segment, among other new disclosure requirements. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance with respect to the consolidated financial statements and disclosures.
91
Note 14. Subsequent Events
The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.
On April 16, 2024, the Company caused notice to be issued to the holders of its 2025 Notes regarding the Company’s exercise of its option to redeem a portion of the issued and outstanding 2025 Notes.
92
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “the Company” refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10‑Q.
Forward-Looking Statements
This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. “Risk Factors” of Part II of this quarterly report and Item 1A. "Risk Factors" of Part I of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission ("SEC") on March 6, 2024, including but not limited to the following:
93
Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the SEC. Any forward-looking statements in this report should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 27A(b)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995).
Overview
We are a specialty lending company providing debt, including loans and equipment financings, to growth-stage companies, including venture capital-backed companies and companies with institutional equity investors. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the 1940 Act. We have elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.
Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments. We seek to achieve our investment objective by making investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.
We target investments in growth-stage companies, which are typically private companies, including venture-backed companies and companies with institutional equity investors. We define “growth-stage companies” as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.
Our loans generally may have initial interest-only periods of up to 24 months, and our equipment financings generally begin amortizing immediately. Our loans and equipment financings generally have a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission-critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth-stage companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company’s projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.
Our History
Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.
94
On January 16, 2020, through a series of transactions, we acquired Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P., Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively, the "Legacy Funds") and all of their respective assets, including their respective investment portfolio, as well as Trinity Capital Holdings, LLC, a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions, we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, 2020.
On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding.
On December 5, 2022, the Company entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager (collectively, the “JV Partner”) to co-manage Senior Credit Corp 2022 LLC (the “JV”). The JV invests in secured loans and equipment financings to growth-stage companies that have been originated by the Company. To achieve these goals, the Company has agreed to offer the JV the opportunity to purchase up to 40% in dollar amount, but not less than 25% in dollar amount, of the entire amount of each secured loan and equipment financing advance originated by the Company during the period commencing on September 1, 2022 and ending on June 5, 2026.
Critical Accounting Estimates and Policies
The preparation of our financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Our critical accounting estimates, including those relating to valuation of investments and income recognition, are described below. Please refer to “Note 2 – Summary of Significant Accounting Policies” in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for a discussion of our significant accounting policies.
Valuation of Investments
The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company’s investments are carried at fair value in accordance with the 1940 Act and Accounting Standards Codification (“ASC”) 946, Financial Services — Investment Companies (“ASC 946”) and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company’s Board of Directors (“Board”) in accordance with the provisions of ASC 820 and the 1940 Act.
The SEC adopted Rule 2a-5 under the 1940 Act ("Rule 2a-5"), which establishes a framework for determining fair value in good faith for purposes of the 1940 Act. As adopted, Rule 2a-5 permits boards of directors to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. The SEC also adopted Rule 31a-4 under the 1940 Act (“Rule 31a-4”), which provides the recordkeeping requirements associated with fair value determinations. While the Company's Board has not elected to designate a valuation designee, the Company has adopted certain revisions to its valuation policies and procedures to comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.
95
While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company identifies portfolio investments with respect to which an independent valuation firm assists in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.
Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:
Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).
Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.
Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.
Given the nature of lending to venture capital-backed growth-stage companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.
Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.
Income Recognition
Interest and Dividend Income. The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. Interest income from payment-in-kind ("PIK") represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.
In addition, the Company may also be entitled to an end-of-term (“EOT”) payment. EOT payments to be paid at the termination of the debt agreement are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT is recognized as interest income.
96
Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are accreted into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.
The Company records dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution. The Company recorded $0.2 million in dividend income during the three months ended March 31, 2024 and no dividend income was recorded during the three months ended March 31, 2023.
Fee and Other Income. The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity. In addition, fee income may include fees for originations and administrative agent services rendered by the Company to the JV. Such fees are earned in the period that the services are rendered.
Portfolio Composition and Investment Activity
Portfolio Composition
As of March 31, 2024, our investment portfolio had an aggregate fair value of approximately $1,363.9 million and was comprised of approximately $1,010.8 million in secured loans, $277.6 million in equipment financings, and $75.5 million in equity and warrants, across 128 portfolio companies. As of December 31, 2023, our investment portfolio had an aggregate fair value of approximately $1,275.2 million and was comprised of approximately $885.3 million in secured loans, $336.8 million in equipment financings, and $53.1 million in equity and warrants, across 120 portfolio companies.
A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in the following table as of March 31, 2024 and December 31, 2023:
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||
|
|
|
|
|
Fair |
|
|
|
|
|
Fair |
|
||||
Type |
|
Cost |
|
|
Value |
|
|
Cost |
|
|
Value |
|
||||
Secured Loans |
|
|
74.3 |
% |
|
|
74.1 |
% |
|
|
69.7 |
% |
|
|
69.5 |
% |
Equipment Financing |
|
|
19.7 |
% |
|
|
20.4 |
% |
|
|
25.5 |
% |
|
|
26.4 |
% |
Warrants |
|
|
2.3 |
% |
|
|
2.9 |
% |
|
|
2.3 |
% |
|
|
2.6 |
% |
Equity |
|
|
3.7 |
% |
|
|
2.6 |
% |
|
|
2.5 |
% |
|
|
1.5 |
% |
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
97
The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of March 31, 2024 and December 31, 2023. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||
|
|
|
|
|
Fair |
|
|
|
|
|
Fair |
|
||||
Geographic Region |
|
Cost |
|
|
Value |
|
|
Cost |
|
|
Value |
|
||||
United States |
|
|
|
|
|
|
|
|
|
|
|
|
||||
West |
|
|
31.9 |
% |
|
|
32.1 |
% |
|
|
35.5 |
% |
|
|
36.5 |
% |
Northeast |
|
|
28.8 |
% |
|
|
29.2 |
% |
|
|
29.8 |
% |
|
|
29.9 |
% |
South |
|
|
13.3 |
% |
|
|
14.3 |
% |
|
|
12.8 |
% |
|
|
13.5 |
% |
Mountain |
|
|
9.6 |
% |
|
|
9.4 |
% |
|
|
9.0 |
% |
|
|
8.7 |
% |
Southeast |
|
|
6.1 |
% |
|
|
6.2 |
% |
|
|
3.3 |
% |
|
|
3.3 |
% |
Midwest |
|
|
5.9 |
% |
|
|
5.6 |
% |
|
|
4.9 |
% |
|
|
4.5 |
% |
Senior Credit Corp 2022 LLC (1) |
|
|
0.9 |
% |
|
|
1.0 |
% |
|
|
0.8 |
% |
|
|
0.9 |
% |
International: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Western Europe |
|
|
1.4 |
% |
|
|
1.5 |
% |
|
|
1.7 |
% |
|
|
1.8 |
% |
Canada |
|
|
2.1 |
% |
|
|
0.7 |
% |
|
|
2.2 |
% |
|
|
0.9 |
% |
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
98
Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of March 31, 2024 and December 31, 2023:
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||
|
|
|
|
|
Fair |
|
|
|
|
|
Fair |
|
||||
Industry |
|
Cost |
|
|
Value |
|
|
Cost |
|
|
Value |
|
||||
Finance and Insurance |
|
|
13.3 |
% |
|
|
13.9 |
% |
|
|
10.6 |
% |
|
|
10.5 |
% |
Green Technology |
|
|
10.5 |
% |
|
|
11.4 |
% |
|
|
10.5 |
% |
|
|
11.2 |
% |
Space Technology |
|
|
8.7 |
% |
|
|
9.1 |
% |
|
|
14.1 |
% |
|
|
14.6 |
% |
Consumer Products & Services |
|
|
6.5 |
% |
|
|
6.7 |
% |
|
|
6.5 |
% |
|
|
6.6 |
% |
Real Estate Technology |
|
|
6.6 |
% |
|
|
6.5 |
% |
|
|
7.2 |
% |
|
|
7.2 |
% |
Healthcare Technology |
|
|
6.2 |
% |
|
|
6.1 |
% |
|
|
6.8 |
% |
|
|
6.6 |
% |
Food and Agriculture Technologies |
|
|
5.9 |
% |
|
|
5.8 |
% |
|
|
6.9 |
% |
|
|
7.0 |
% |
Medical Devices |
|
|
5.0 |
% |
|
|
5.3 |
% |
|
|
5.2 |
% |
|
|
5.5 |
% |
Artificial Intelligence & Automation |
|
|
4.6 |
% |
|
|
4.7 |
% |
|
|
2.6 |
% |
|
|
2.7 |
% |
Biotechnology |
|
|
4.0 |
% |
|
|
4.2 |
% |
|
|
4.3 |
% |
|
|
4.4 |
% |
SaaS |
|
|
3.4 |
% |
|
|
3.7 |
% |
|
|
2.6 |
% |
|
|
2.7 |
% |
Marketing, Media, and Entertainment |
|
|
3.4 |
% |
|
|
3.4 |
% |
|
|
3.7 |
% |
|
|
3.7 |
% |
Diagnostics & Tools |
|
|
3.0 |
% |
|
|
3.1 |
% |
|
|
— |
|
|
|
— |
|
Education Technology |
|
|
3.0 |
% |
|
|
2.9 |
% |
|
|
1.4 |
% |
|
|
1.2 |
% |
Connectivity |
|
|
2.5 |
% |
|
|
2.6 |
% |
|
|
2.7 |
% |
|
|
2.7 |
% |
Human Resource Technology |
|
|
2.2 |
% |
|
|
2.3 |
% |
|
|
2.4 |
% |
|
|
2.4 |
% |
Transportation Technology |
|
|
3.1 |
% |
|
|
2.1 |
% |
|
|
3.4 |
% |
|
|
3.1 |
% |
Supply Chain Technology |
|
|
2.2 |
% |
|
|
1.9 |
% |
|
|
2.3 |
% |
|
|
1.9 |
% |
Digital Assets Technology and Services |
|
|
1.9 |
% |
|
|
1.5 |
% |
|
|
2.5 |
% |
|
|
2.8 |
% |
Industrials |
|
|
1.3 |
% |
|
|
1.4 |
% |
|
|
1.7 |
% |
|
|
1.8 |
% |
Multi-Sector Holdings (1) |
|
|
0.9 |
% |
|
|
1.0 |
% |
|
|
0.8 |
% |
|
|
0.9 |
% |
Construction Technology |
|
|
1.8 |
% |
|
|
0.4 |
% |
|
|
1.8 |
% |
|
|
0.5 |
% |
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
As of March 31, 2024 and December 31, 2023, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately 3.1 and 3.2 years, respectively. Additional information regarding our portfolio is set forth in the Consolidated Schedule of Investments and the related notes thereto included with this Quarterly Report on Form 10-Q.
Concentrations of Credit Risk
Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.
As of March 31, 2024 and December 31, 2023, the Company’s ten largest portfolio companies represented approximately 27.1% and 31.6%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of March 31, 2024 and December 31, 2023, the Company had eight and four portfolio companies, respectively, that represented 5% or more of the Company’s net assets.
99
Investment Activity
During the three months ended March 31, 2024, we invested approximately $182.9 million in eight new portfolio companies, approximately $57.4 million in 12 existing portfolio companies, and approximately $2.4 million in the JV, excluding deferred fees. During the three months ended March 31, 2024, we received an aggregate of $148.5 million in proceeds from repayments and sales of our investments, including proceeds of approximately $43.4 million from early repayments on our debt investments and $55.4 million sales of debt investments.
During the year ended December 31, 2023, we invested approximately $414.3 million in 17 new portfolio companies, approximately $216.5 million in 25 existing portfolio companies, and approximately $11.0 million in the JV, excluding deferred fees. During the year ended December 31, 2023, we received an aggregate of $471.9 million in proceeds from repayments and sales of our investments, including proceeds of approximately $326.6 million from early repayments on our debt investments and sales of debt investments.
The following table provides a summary of the changes in the investment portfolio for the three months ended March 31, 2024 and the year ended December 31, 2023 (in thousands):
|
|
|
|
|
|
Three Months Ended |
|
|
Year Ended |
|
||
|
|
|
|
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||
Beginning Portfolio, at fair value |
|
|
|
|
|
$ |
1,275,180 |
|
|
$ |
1,094,386 |
|
Purchases, net of deferred fees |
|
|
|
|
|
|
240,700 |
|
|
|
632,754 |
|
Non-cash conversion |
|
|
|
|
|
|
— |
|
|
|
21 |
|
Principal payments received on investments |
|
|
|
|
|
|
(41,902 |
) |
|
|
(142,113 |
) |
Proceeds from early debt repayments |
|
|
|
|
|
|
(43,411 |
) |
|
|
(169,745 |
) |
Sales of investments |
|
|
|
|
|
|
(63,228 |
) |
|
|
(160,068 |
) |
Accretion of OID, EOT, and PIK payments |
|
|
|
|
|
|
7,172 |
|
|
|
32,953 |
|
Net realized gain/(loss) |
|
|
|
|
|
|
1,351 |
|
|
|
(28,071 |
) |
Change in unrealized appreciation/(depreciation) |
|
|
|
|
|
|
(12,000 |
) |
|
|
15,063 |
|
Ending Portfolio, at fair value |
|
|
|
|
|
$ |
1,363,862 |
|
|
$ |
1,275,180 |
|
The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth-stage companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.
Portfolio Asset Quality
Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our investment committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its audit committee.
100
For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.
The following table shows the distribution of our secured loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of March 31, 2024 and December 31, 2023 (dollars in thousands):
|
|
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
||||||||||
Investment Risk Rating |
|
|
|
Investments at |
|
|
Percentage of |
|
|
Investments at |
|
|
Percentage of |
|
||||
Scale Range |
|
Designation |
|
Fair Value |
|
|
Total Portfolio |
|
|
Fair Value |
|
|
Total Portfolio |
|
||||
4.0 - 5.0 |
|
Very Strong Performance |
|
$ |
56,991 |
|
|
|
4.4 |
% |
|
$ |
40,584 |
|
|
|
3.3 |
% |
3.0 - 3.9 |
|
Strong Performance |
|
|
275,107 |
|
|
|
21.4 |
% |
|
|
277,867 |
|
|
|
22.9 |
% |
2.0 - 2.9 |
|
Performing |
|
|
875,950 |
|
|
|
68.0 |
% |
|
|
805,730 |
|
|
|
65.9 |
% |
1.6 - 1.9 |
|
Watch |
|
|
65,410 |
|
|
|
5.1 |
% |
|
|
56,740 |
|
|
|
4.6 |
% |
1.0 - 1.5 |
|
Default/Workout |
|
|
5,539 |
|
|
|
0.4 |
% |
|
|
33,452 |
|
|
|
2.7 |
% |
Total Debt Investments excluding Senior Credit Corp 2022 LLC |
|
|
|
|
1,278,997 |
|
|
|
99.3 |
% |
|
|
1,214,373 |
|
|
|
99.4 |
% |
. |
|
Senior Credit Corp 2022 LLC (1) |
|
|
9,394 |
|
|
|
0.7 |
% |
|
|
7,704 |
|
|
|
0.6 |
% |
Total Debt Investments |
|
|
|
$ |
1,288,391 |
|
|
|
100.0 |
% |
|
$ |
1,222,077 |
|
|
|
100.0 |
% |
As of both March 31, 2024 and December 31, 2023, our debt investments had a weighted average risk rating score of 2.7.
Debt Investments on Non-Accrual Status
When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable
101
is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.
As of March 31, 2024, loans to four portfolio companies and equipment financings to one portfolio company were on non-accrual status with a total cost of approximately $67.5 million, and a total fair value of approximately $30.4 million, or 2.4%, of the fair value of the Company’s debt investment portfolio. As of December 31, 2023, loans to three portfolio companies and equipment financings to two portfolio companies were on non-accrual status with a total cost of approximately $60.8 million, and a total fair value of approximately $43.2 million, or 3.5%, of the fair value of the Company’s debt investment portfolio.
Results of Operations
The following discussion and analysis of our results of operations encompasses our consolidated results for the three months ended March 31, 2024 and 2023.
Investment Income
The following table sets forth the components of investment income (in thousands). The components of investment income have been updated to a preferred presentation and the prior year has been amended to conform with the new preferred presentation.
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||||
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
||||
Stated interest income |
|
$ |
|
37,840 |
|
|
$ |
|
33,804 |
|
Amortization of OID and EOT |
|
|
|
6,310 |
|
|
|
|
5,049 |
|
Acceleration of OID and EOT |
|
|
|
951 |
|
|
|
|
1,332 |
|
PIK interest income |
|
|
|
4,091 |
|
|
|
|
346 |
|
Dividend income |
|
|
|
200 |
|
|
|
|
— |
|
Other fee income |
|
|
|
1,061 |
|
|
|
|
1,007 |
|
Total investment income |
|
$ |
|
50,453 |
|
|
$ |
|
41,538 |
|
For the three months ended March 31, 2024, total investment income was approximately $50.5 million, which represents an approximate effective yield of 15.8% on the average investments during the year. For the three months ended March 31, 2023, total investment income was approximately $41.5 million, which represents an approximate effective yield of 15.2% on the average investments during the year. The increase in investment income for the three months ended March 31, 2024 is due to higher interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and higher stated interest rates.
Operating Expenses and Excise Taxes
Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees, general and administrative expenses, and excise taxes. Our operating expenses totaled approximately $25.3 million and $22.2 million for the three months ended March 31, 2024 and 2023, respectively. The increase in our operating expenses for the three months ended March 31, 2024 is discussed with respect to each component of such expenses below.
Interest Expense and Other Debt Financing Costs
Our interest expense and other debt financing costs are primarily comprised of interest and fees related to our secured borrowings, the 7.00% Notes due 2025 (the “2025 Notes”), the 4.375% Notes due 2026 (the “August 2026 Notes”), the 4.25% Notes due 2026 (the “December 2026 Notes”), the 7.875% Notes due 2029 (the “March 2029 Notes”), and the 6.00% Convertible Notes due 2025 (the “Convertible Notes”). Interest expense and other debt financing costs on our borrowings totaled approximately $12.1 million and $11.1 million for the three months ended March 31, 2024 and 2023, respectively. Our weighted average effective interest rate, comprised of interest and
102
amortization of fees and discounts, was approximately 7.4% and 7.0% for three months ended March 31, 2024 and 2023, respectively. The increase in interest expense for the three months ended March 31, 2024 was primarily due to increased borrowings and increased base rate under our credit facility with KeyBank, National Association (the “KeyBank Credit Facility”).
Employee Compensation and Benefits
Employee compensation and benefits totaled approximately $9.9 million and $7.6 million for the three months ended March 31, 2024 and 2023, respectively. The increase in employee compensation expenses for the three months ended March 31, 2024 relates primarily to the increased variable compensation related to a higher headcount and stock-based compensation. As of March 31, 2024 and 2023, the Company had 73 and 55 employees, respectively.
Professional Fees Expenses
Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees, totaled approximately $0.7 million and $1.4 million for the three months ended March 31, 2024 and 2023, respectively. The decrease in professional fees expenses for the three months ended March 31, 2024 resulted primarily from a decrease in legal fees, third-party valuation fees and other consulting fees.
General and Administrative Expenses
General and administrative expenses include insurance premiums, rent, state taxes and various other expenses related to our ongoing operations. Our general and administrative expenses totaled approximately $2.0 million and $1.5 million for the three months ended March 31, 2024 and 2023, respectively. The increase in general and administrative expenses for the three months ended March 31, 2024 was primarily due to additional office rent and related expenses.
Excise Taxes
Our excise taxes totaled approximately $0.6 million and $0.6 million for the three months ended March 31, 2024 and 2023, respectively.
Net Investment Income
For the three months ended March 31, 2024, we recognized approximately $50.5 million in total investment income as compared to approximately $25.3 million in total expenses, including excise tax expense, resulting in net investment income of $25.2 million. For the three months ended March 31, 2023 we recognized approximately $41.5 million in total investment income as compared to approximately $22.2 million in total expenses including excise tax expense, resulting in net investment income of $19.3 million.
Net Realized Gains and Losses
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period.
During the three months ended March 31, 2024, our gross realized gains primarily consisted of the repayment of one equipment financing, and our gross realized losses primarily consisted of the partial sale of one equity position in a portfolio company. During the three months ended March 31, 2023, our gross realized gains primarily consisted of the repayment of one equipment financing, and our gross realized losses primarily consisted of the repayment of our debt positions in two portfolio companies.
103
The net realized gains (losses) from the sales, repayments, or exits of investments for the three months ended March 31, 2024 and 2023 were comprised of the following (in thousands):
|
|
|
Three Months Ended |
|
|
|
Three Months Ended |
|
||
|
|
|
March 31, 2024 |
|
|
|
March 31, 2023 |
|
||
Net realized gain/(loss) on investments: |
|
|
|
|
|
|
|
|
||
Gross realized gains |
|
$ |
|
4,277 |
|
|
$ |
|
539 |
|
Gross realized losses |
|
|
|
(2,926 |
) |
|
|
|
(904 |
) |
Total net realized gains/(losses) on investments |
|
$ |
|
1,351 |
|
|
$ |
|
(365 |
) |
Net Change in Unrealized Appreciation / (Depreciation) from Investments
Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.
Net unrealized appreciation and depreciation on investments for the three months ended March 31, 2024 and 2023 is comprised of the following (in thousands):
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||||
|
|
March 31, 2024 |
|
|
March 31, 2023 |
|
||||
Gross unrealized appreciation |
|
$ |
|
19,057 |
|
|
$ |
|
17,803 |
|
Gross unrealized depreciation |
|
|
|
(28,980 |
) |
|
|
|
(14,600 |
) |
Net unrealized appreciation/(depreciation) reclassified related to net realized gains or losses |
|
|
|
(2,077 |
) |
|
|
|
317 |
|
Total net unrealized gains/(losses) on investments |
|
$ |
|
(12,000 |
) |
|
$ |
|
3,520 |
|
During the three months ended March 31, 2024, our net unrealized depreciation totaled approximately $12.0 million, which included net unrealized appreciation of $3.8 million from our warrant investments, net unrealized depreciation of $3.4 million from our equity investments and net unrealized depreciation of $12.4 million from our debt investments.
During the three months ended March 31, 2023, our net unrealized appreciation totaled approximately $3.5 million, which included net unrealized depreciation of $4.8 million from our warrant investments, net unrealized appreciation of $0.1 million from our equity investments and net unrealized appreciation of $8.2 million from our debt investments.
Net Increase (Decrease) in Net Assets Resulting from Operations
Net increase in net assets resulting from operations during the three months ended March 31, 2024, totaled approximately $14.5 million. Net increase in net assets resulting from operations during the three months ended March 31, 2023, totaled approximately $22.5 million.
Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share
For the three months ended March 31, 2024, basic and diluted net increase in net assets per common share were $0.31 and 0.30, respectively. For the three months ended March 31, 2023, basic and diluted net decrease in net assets per common share was $0.64 and $0.60, respectively.
Financial Condition, Liquidity and Capital Resources
Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our “at-the-market” offering, the 2025 Notes offering, the Convertible Notes offering, the August 2026
104
Notes offering, the December 2026 Notes offering and the March 2029 Notes offering, borrowings under the KeyBank Credit Facility, and cash flows from our operations, including investment sales and repayments, as well as income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the KeyBank Credit Facility or any future credit facility, as well as proceeds from the turnover of our portfolio, to finance our investment objectives and activities.
From time to time, we may enter into additional credit facilities, increase the size of our existing KeyBank Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.
For the three months ended March 31, 2024, we experienced a net increase in cash and cash equivalents in the amount of $7.2 million, which is the net result of $88.6 million of cash provided by financing activities, offset by $81.4 million of cash used in operating activities and less than $0.1 million of cash used in investing activities. During the three months ended March 31, 2023, we experienced a net decrease in cash and cash equivalents in the amount of $2.3 million, which is the net result of $22.7 million of cash used in financing activities and $0.3 million of cash used in investing activities, offset by $20.7 million of cash provided by operating activities.
As of March 31, 2024 and December 31, 2023, we had cash and cash equivalents of $12.0 million and $4.8 million, respectively, of which $4.9 million and $3.1 million, respectively, was held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote.
As of March 31, 2024 and December 31, 2023, we had approximately $160.0 million and $137.0 million, respectively, of available borrowings under the KeyBank Credit Facility, subject to its terms and regulatory requirements. Cash and cash equivalents, taken together with available borrowings under the KeyBank Credit Facility, as of March 31, 2024, are expected to be sufficient for our investing activities and to conduct our operations in the near term and long term.
Refer to “Note 5 – Borrowings” in the notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q for a discussion of our borrowings.
Asset Coverage Requirements
In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, we are permitted to potentially borrow $2 for investment purposes of every $1 of investor equity. As of March 31, 2024, our asset coverage ratio was approximately 184.9% and our asset coverage ratio per unit was approximately $1,849. As of December 31, 2023, our asset coverage ratio was approximately 194.7% and our asset coverage ratio per unit was approximately $1,947.
Commitments and Off-Balance Sheet Arrangements
The Company has entered into a capital commitment with the JV to fund capital contributions through June 2026 in the amount of $21.4 million, of which $8.0 million and $10.4 million was unfunded as of March 31, 2024 and December 31, 2023, respectively. The Company did not have any other off-balance sheet financings or liabilities as of March 31, 2024 or December 31, 2023, respectively.
105
The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of March 31, 2024 and December 31, 2023 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. As of March 31, 2024 and December 31, 2023, the Company did not have any outstanding unfunded commitments. The Company will fund future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the KeyBank Credit Facility).
In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.
Contractual Obligations
A summary of our contractual payment obligations as of March 31, 2024, is as follows:
|
|
Payments Due by Period |
|
|
|
|
||||||||||||||
|
|
Less than 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
year |
|
|
1 - 3 years |
|
|
4 - 5 years |
|
|
After 5 years |
|
|
Total |
|
|||||
KeyBank Credit Facility |
|
$ |
— |
|
|
$ |
190,000 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
190,000 |
|
2025 Notes |
|
|
182,500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
182,500 |
|
Convertible Notes |
|
|
— |
|
|
|
50,000 |
|
|
|
— |
|
|
|
— |
|
|
|
50,000 |
|
August 2026 Notes |
|
|
— |
|
|
|
125,000 |
|
|
|
— |
|
|
|
— |
|
|
|
125,000 |
|
December 2026 Notes |
|
|
— |
|
|
|
75,000 |
|
|
|
— |
|
|
|
— |
|
|
|
75,000 |
|
March 2029 Notes |
|
|
— |
|
|
|
— |
|
|
|
115,000 |
|
|
|
— |
|
|
|
115,000 |
|
Operating Leases |
|
|
743 |
|
|
|
3,001 |
|
|
|
1,966 |
|
|
|
1,429 |
|
|
|
7,139 |
|
Total Contractual Obligations |
|
$ |
183,243 |
|
|
$ |
443,001 |
|
|
$ |
116,966 |
|
|
$ |
1,429 |
|
|
$ |
744,639 |
|
Distributions
We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.
106
The following table summarizes distributions declared and/or paid by the Company since inception:
Declaration |
|
Type |
|
Record |
|
Payment |
|
Per Share |
|
|
May 7, 2020 |
|
Quarterly |
|
May 29, 2020 |
|
June 5, 2020 |
|
$ |
0.22 |
|
August 10, 2020 |
|
Quarterly |
|
August 21, 2020 |
|
September 4, 2020 |
|
|
0.27 |
|
November 9, 2020 |
|
Quarterly |
|
November 20, 2020 |
|
December 4, 2020 |
|
|
0.27 |
|
December 22, 2020 |
|
Quarterly |
|
December 30, 2020 |
|
January 15, 2021 |
|
|
0.27 |
|
March 23, 2021 |
|
Quarterly |
|
March 31, 2021 |
|
April 16, 2021 |
|
|
0.28 |
|
June 15, 2021 |
|
Quarterly |
|
June 30, 2021 |
|
July 15, 2021 |
|
|
0.29 |
|
September 13, 2021 |
|
Quarterly |
|
September 30, 2021 |
|
October 15, 2021 |
|
|
0.33 |
|
December 16, 2021 |
|
Quarterly |
|
December 31, 2021 |
|
January 14, 2022 |
|
|
0.36 |
|
March 15, 2022 |
|
Quarterly |
|
March 31, 2022 |
|
April 15, 2022 |
|
|
0.40 |
|
March 15, 2022 |
|
Supplemental |
|
March 31, 2022 |
|
April 15, 2022 |
|
|
0.15 |
|
June 15, 2022 |
|
Quarterly |
|
June 30, 2022 |
|
July 15, 2022 |
|
|
0.42 |
|
June 15, 2022 |
|
Supplemental |
|
June 30, 2022 |
|
July 15, 2022 |
|
|
0.15 |
|
September 15, 2022 |
|
Quarterly |
|
September 30, 2022 |
|
October 14, 2022 |
|
|
0.45 |
|
September 15, 2022 |
|
Supplemental |
|
September 30, 2022 |
|
October 14, 2022 |
|
|
0.15 |
|
December 15, 2022 |
|
Quarterly |
|
December 30, 2022 |
|
January 13, 2023 |
|
|
0.46 |
|
December 15, 2022 |
|
Supplemental |
|
December 30, 2022 |
|
January 13, 2023 |
|
|
0.15 |
|
March 14, 2023 |
|
Quarterly |
|
March 31, 2023 |
|
April 14, 2023 |
|
|
0.47 |
|
June 14, 2023 |
|
Quarterly |
|
June 30, 2023 |
|
July 14, 2023 |
|
|
0.48 |
|
June 14, 2023 |
|
Supplemental |
|
June 30, 2023 |
|
July 14, 2023 |
|
|
0.05 |
|
September 13, 2023 |
|
Quarterly |
|
September 30, 2023 |
|
October 13, 2023 |
|
|
0.49 |
|
September 13, 2023 |
|
Supplemental |
|
September 30, 2023 |
|
October 13, 2023 |
|
|
0.05 |
|
December 14, 2023 |
|
Quarterly |
|
December 29, 2023 |
|
January 12, 2024 |
|
|
0.50 |
|
March 14, 2024 |
|
Quarterly |
|
March 28, 2024 |
|
April 15, 2024 |
|
|
0.51 |
|
|
|
|
|
|
|
Total |
|
$ |
7.17 |
|
Price Range of Common Stock
Our common stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on January 29, 2021 under the symbol “TRIN” in connection with our IPO, which closed on February 2, 2021. Prior to our IPO, the shares of our common stock were offered and sold in transactions exempt from registration under the Securities Act. As such, there was no public market for shares of our common stock during year ended December 31, 2020. Since our IPO, our common stock has traded at prices both above and below our net asset value per share.
The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on Nasdaq, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on Nasdaq. On April 30, 2024, the last reported closing sales price of our common stock on Nasdaq was $
107
2024, we had approximately 56 stockholders of record, which does not include stockholders for whom shares are held in nominee or “street” name.
|
|
|
|
|
Price Range |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Class and Period |
|
Net Asset Value(1) |
|
|
High |
|
|
Low |
|
|
High Sales Price Premium (Discount) to Net Asset Value(2) |
|
Low Sales Price Premium (Discount) to Net Asset Value(2) |
|
Cash Dividend Per Share(3) |
|
|
||||||||||
Year Ending December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Second Quarter (through April 30, 2024) |
|
* |
|
|
$ |
|
|
$ |
|
|
* |
|
|
|
* |
|
|
|
* |
|
|
||||||
First Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
|
% |
|
$ |
0.51 |
|
|
|||||
Year Ending December 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Fourth Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
|
% |
|
$ |
0.50 |
|
|
|||||
Third Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
|
% |
|
$ |
0.54 |
|
(4) |
|||||
Second Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
( |
) |
% |
|
$ |
0.53 |
|
(4) |
||||
First Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
( |
) |
% |
|
$ |
0.47 |
|
|
||||
Year Ending December 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Fourth Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
( |
) |
% |
|
$ |
0.61 |
|
(4) |
||||
Third Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
( |
) |
% |
|
$ |
0.60 |
|
(4) |
||||
Second Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
( |
) |
% |
|
$ |
0.57 |
|
(4) |
||||
First Quarter |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
% |
|
|
|
% |
|
$ |
0.55 |
|
(4) |
* |
Not determined at time of filing. |
Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. At times, our shares of common stock have traded at prices both above and below our net asset value per share. The possibility that our shares of common stock will trade at a discount from net asset value per share or at premiums that are unsustainable over the long term are separate and distinct from the risk that our net asset value per share will decrease. It is not possible to predict whether our common stock will trade at, above, or below net asset value per share.
Related Party Transactions
Certain members of management as well as employees of the Company hold shares of the Company’s stock.
We have entered into indemnification agreements with our directors and executive officers. The indemnification agreements are intended to provide our directors and executive officers with the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that we shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.
Refer to “Note 12 – Related Party Transactions” included in the notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.
108
Recent Developments
On April 16, 2024, we caused notice to be issued to the holders of our 2025 Notes regarding our exercise of our option to redeem a portion of the issued and outstanding 2025 Notes. We will redeem $30.0 million in aggregate principal amount of the $182.5 million in aggregate principal amount of outstanding 2025 Notes on May 17, 2024 (the “Redemption Date”). The 2025 Notes will be redeemed at 100% of their principal amount ($25 per Note), plus the accrued and unpaid interest thereon from March 15, 2024, to, but excluding, the Redemption Date.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the overall market conditions has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.
Valuation Risk
Our investments may not have readily available market quotations (as such term is defined in Rule 2a-5), and those investments which do not have readily available market quotations are valued at fair value as determined in good faith by our Board of Directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.
In accordance with Rule 2a-5, our Board periodically assesses and manages material risks associated with the determination of the fair value of our investments.
Interest Rate Risk
Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the KeyBank Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates, including as a result of inflation, will not have a material adverse effect on our net investment income. Inflation is likely to continue in the near to medium-term, particularly in the United States and Europe, with the possibility that monetary policy may tighten in response. Persistent inflationary pressures could affect our portfolio companies’ profit margins.
As of March 31, 2024, approximately 75.4% of our debt investments based on outstanding principal balance represented floating-rate investments based on Prime or SOFR, and approximately 24.6% of our debt investments based on outstanding principal balance represented fixed rate investments. In addition, borrowings under the KeyBank Credit Facility are subject to floating interest rates based on SOFR, generally bearing interest at a rate of the Adjusted Term SOFR Reference Rate plus 2.85%, subject to the number of eligible debt investments in the collateral pool.
Based on our Consolidated Statements of Operations as of March 31, 2024, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime rate on our debt investments (considering interest rate floors for floating-rate instruments) and the hypothetical base rate changes in the SOFR on
109
our KeyBank Credit Facility, assuming that there are no changes in our investment and borrowing structure (in thousands):
|
|
Interest |
|
|
Interest |
|
|
Net |
|
|||
|
|
Income |
|
|
Expense |
|
|
Income/(Loss) |
|
|||
Up 300 basis points |
|
$ |
27,369 |
|
|
$ |
5,700 |
|
|
$ |
21,669 |
|
Up 200 basis points |
|
$ |
18,307 |
|
|
$ |
3,800 |
|
|
$ |
14,507 |
|
Up 100 basis points |
|
$ |
9,455 |
|
|
$ |
1,900 |
|
|
$ |
7,555 |
|
Down 100 basis points |
|
$ |
(7,392 |
) |
|
$ |
(1,900 |
) |
|
$ |
(5,492 |
) |
Down 200 basis points |
|
$ |
(12,571 |
) |
|
$ |
(3,800 |
) |
|
$ |
(8,771 |
) |
Down 300 basis points |
|
$ |
(17,240 |
) |
|
$ |
(5,700 |
) |
|
$ |
(11,540 |
) |
Currency Risk
Any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of March 31, 2024, we had four foreign domiciled portfolio companies. Our exposure to currency risk related to these debt investments is minimal as payments from such portfolio companies are received in U.S. dollars. No other investments as of March 31, 2024 were subject to currency risk.
Hedging
We do not currently engage in any hedging activities. However, we may, in the future, hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.
110
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
In accordance with Rules 13a-15(b) and 15d-15(b) under the Exchange Act, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of any future legal or regulatory proceedings cannot be predicted with certainty, we do not expect that any such future proceedings will have a material effect upon our financial condition or results of operations.
Item 1A. Risk Factors
Investing in our securities involves a number of significant risks. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K filed with the SEC on March 6, 2024, all of which could materially affect our business, financial condition and/or results of operations. Although the risks described in our other SEC filings referenced above represent the principal risks associated with an investment in us, they are not the only risks we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, might materially and adversely affect our business, financial condition and/or results of operations.
During the three months ended March 31, 2024, there have been no material changes to the risk factors discussed in our SEC filings referenced above.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Dividend Reinvestment Plan
On April 15, 2024, pursuant to its amended and restated distribution reinvestment plan, the Company issued 22,578 shares of its common stock, at a price of $14.03 per share, to stockholders of record as of March 28, 2024 that did not opt out of the Company’s amended and restated distribution reinvestment plan in order to satisfy the reinvestment portion of the Company’s distribution. This issuance was not subject to the registration requirements of the Securities Act. See “Item 1. Consolidated Financial Statements – Note 7. Stockholder’s Equity – Distribution Reinvestment Plan” for more information.
111
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable.
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the fiscal quarter ended March 31, 2024, none of the Company's directors or executive officers
Item 6. Exhibits
The following exhibits are filed as part of this Quarterly Report on Form 10‑Q or hereby incorporated by reference to exhibits previously filed with the SEC:
|
|
|
Exhibit |
|
Description of Exhibits |
3.1 |
|
|
3.2 |
|
|
4.1 |
|
|
4.2 |
|
|
31.1* |
|
|
31.2* |
|
|
32.1** |
|
|
32.2** |
|
|
101.INS* |
|
Inline XBRL Instance Document. |
101.SCH* |
|
Inline XBRL Taxonomy Extension Schema Document. |
101.CAL* |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF* |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB* |
|
Inline XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE* |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
104* |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
* Filed herewith
** Furnished herewith
112
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
TRINITY CAPITAL INC. |
|
|
|
|
Dated: May 1, 2024 |
By: |
/s/ Kyle Brown |
|
|
Kyle Brown |
|
|
Chief Executive Officer, President and Chief |
|
|
Investment Officer (Principal Executive Officer) |
|
|
|
|
|
|
Dated: May 1, 2024 |
By: |
/s/ Michael Testa |
|
|
Michael Testa |
|
|
Chief Financial Officer and Treasurer |
|
|
(Principal Financial and Accounting Officer) |
113
Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kyle Brown, Chief Executive Officer of Trinity Capital Inc., certify that:
|
|
|
Date: May 1, 2024 |
By: |
/s/ Kyle Brown |
|
|
Kyle Brown |
|
|
Chief Executive Officer |
Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael Testa, Chief Financial Officer of Trinity Capital Inc., certify that:
|
|
|
Date: May 1, 2024 |
By: |
/s/ Michael Testa |
|
|
Michael Testa |
|
|
Chief Financial Officer and Treasurer |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of Trinity Capital Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:
|
|
|
Date: May 1, 2024 |
By: |
/s/ Kyle Brown |
|
|
Kyle Brown |
|
|
Chief Executive Officer |
Exhibit 32.2
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of Trinity Capital Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:
|
|
|
Date: May 1, 2024 |
By: |
/s/ Michael Testa |
|
|
Michael Testa |
|
|
Chief Financial Officer and Treasurer |